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Abstract 
Muscle contraction and relaxation is initiated by changes in intracellular calcium, 
making adequate calcium transport essential for proper muscle function. A primary 
calcium
 
transporter is the sarcoendoplasmic reticulum Ca
2+
-ATPase (SERCA), located 
within the muscle cell and embedded in an organelle called the sarcoplasmic reticulum 
(SR). To facilitate muscle relaxation, calcium is sequestered from the cellular cytosol into 
the SR by SERCA. In cardiac muscle, enhanced regulation of calcium transport is needed 
to accommodate -adrenergic stimulation (adrenaline demand), which is provided by the 
regulatory protein phospholamban (PLB). PLB binds to SERCA and inhibits calcium 
transport through reduction in calcium affinity. However, a phosphate group can be 
attached to PLB during adrenaline response (phosphorylation) which relieves PLB’s 
inhibitory effect. The structural mechanisms for SERCA regulation by PLB, particularly 
with respect to phosphorylation, are not well-resolved. Under the Dissociation Model, 
PLB phosphorylation relieves SERCA inhibition by dissociating the SERCA-PLB 
complex. In contrast, the Subunit Model proposes that SERCA inhibition is relieved by a 
subtle structural change, where the SERCA-PLB complex is preserved. 
 The primary goal of my thesis work is to elucidate the structural mechanisms of 
the SERCA-PLB complex using electron paramagnetic resonance (EPR) spectroscopy. 
The first study (Chapter 3) aims to discriminate between the Dissociation and Subunit 
models by measuring changes in the rotational diffusion of EPR spin labels rigidly 
coupled to PLB and SERCA. The second study (Chapter 4) further develops an 
anisotropic membrane system called bicelles for EPR orientation measurements on PLB 
  vii 
and SERCA. The third study (Chapter 5) uses a combination of oriented bicelles and a 
novel rigid spin label (bifunctional spin label, or BSL) to measure PLB topology in the 
lipid membrane, with comparison to previous structural measurements by NMR and x-
ray crystallography. Ongoing studies (Chapter 6) reconstitute both spin-labeled PLB and 
SERCA in bicelles to make PLB orientation measurements by EPR, as affected by PLB 
phosphorylation and binding of SERCA. 
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Chapter 1: Calcium-Regulated Muscle Physiology 
 
1.1 Mechanics of Muscle Contractility 
 Muscle is a soft tissue present in most animals, and is responsible for executing 
motor function in the body. It is comprised of thin (actin) and thick (myosin) filaments 
that slide between each other, enabling the muscle to extend and contract as needed to 
accomplish movement. This is referred to as the sliding filament model, proposed in 1954 
by Andrew and Hugh Huxley and co-workers [2, 3]. Specifically, myosin forms cross-
 
Fig. 1. Functional model of calcium transport. Calcium transported by the L-type calcium 
channels (ICa in figure) during action potential stimulates release of calcium from the sarcoplasmic 
reticulum (SR) by the ryanodine receptors (RyR) into the cellular cytosol, followed by myofilament 
contraction. To facilitate muscle relaxation, calcium is taken back into the SR by the calcium 
ATPase SERCA (ATP in figure), which is regulated by phospholamban (PLB). Figure reprinted 
from [1]. 
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bridges with the actin filament, and through hydrolysis of adenosine triphosphate (ATP), 
undergoes conformational changes that contracts the muscle fiber [4]. The ability of 
myosin to bind to the actin filament is regulated by tropomyosin, a coiled coil protein 
which lines the actin filament, and may either block or reveal the myosin-binding sites on 
actin [5]. The troponin complex, comprised of troponin C, T, and I, regulates the position 
of tropomyosin on the actin filament. In particular, troponin I shifts conformation when 
calcium is bound to it, exposing the myosin binding sites and leading to muscle 
contraction [6]. Calcium is therefore an essential component of proper muscle 
contractility regulation. 
 
1.2 Intracellular Calcium Transport 
 Free calcium (Ca
2+
) is an essential signaling chemical for many biochemical 
processes, including bone production, programmed cell death, and muscle contractility 
[7]. Fig. 1 shows the essential components of intracellular calcium transport. Calcium is 
transported into the cell through the L-type calcium channel, located in the sarcolemmal 
t-tubules. The L-type calcium channel is voltage-dependent, responding to action 
potentials propagated across the sarcolemma. Calcium transported by the L-type calcium 
channel stimulates the ryanodine receptor (RyR), a calcium transporter embedded in the 
sarcoplasmic reticulum (SR), to release micromolar calcium from the SR into the cellular 
cytosol, activating calcium-dependent processes such as muscle contraction. To reverse 
these processes, calcium must be removed from the cytosol. It can be removed from the 
cell through the plasma membrane calcium ATPase (PMCA) and the sodium calcium 
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exchanger (NCX); however, 70% of calcium removal is accomplished by the sarco-
endoplasmic reticulum calcium ATPase (SERCA) [8]. SERCA is embedded in the SR 
membrane, hydrolyzing ATP to pump calcium from the cytosol into the SR. In cardiac 
muscle cells, SERCA activity is allosterically regulated by phospholamban (PLB) [9, 10]. 
 
1.3 SERCA: The SR Calcium ATPase 
 SERCA is a P-type calcium ATPase, autophosphorylating during its catalytic 
cycle of hydrolyzing ATP to transport calcium from the cellular cytosol into the SR. It is 
embedded in the SR membrane, and is encoded by three genes: ATP2A1 (SERCA1), 
ATP2A2 (SERCA2), and ATP2A3 (SERCA3) [12]. SERCA1a is primarily expressed in 
fast-twitch skeletal muscle [13], SERCA2a is primarily expressed in cardiac and slow-
twitch skeletal muscle [14], and SERCA3a is primarily expressed in non-muscle tissue 
such as epithelial and endothelial cells [15]. SERCA1a is well-studied due to its 
abundance and ease of purification. It is also ~84% homologous to the cardiac variant 
SERCA2a, and possesses similar interactions with PLB [16, 17]. The studies performed 
in this thesis use the SERCA1a isoform, purified from rabbit skeletal muscle, and 
SERCA1a will be referred to as SERCA subsequently. 
 SERCA comprises four structural domains (Fig. 2) [11]. The transmembrane (M) 
domain contains 10 TM helices (M1-M10), forming the calcium channel between the 
cytosol and SR, as well as the two calcium-binding sites. Site I is coordinated with Glu 
771 (M5), Asp 800 (M6), Glu 908 (M8), Asp 768 (M5), Thr 799 (M6), as well as two 
water molecules. Site II is coordinated with Glu 309 (M4), Val 304 (M4), Ala 305 (M4),  
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Ile 307 (M4), Asp 800 (M6) and Asn 796 (M6) [12, 18]. The phosphorylation (P) domain 
is directly above the M domain. During SERCA’s catalytic cycle, residue Asp356 is 
phosphorylated, inducing conformational changes within SERCA that facilitate calcium 
transport. The actuator (A) domain is adjacent to the P domain, and is responsible for 
translating calcium and phosphorylation-dependent conformational changes throughout 














Fig. 2. SERCA1a E2 crystal structure (1IWO) [11]. SERCA is a calcium ATPase, hydrolyzing ATP 
to transport calcium ions from the cytoplasm into the SR. The transmembrane domain (M, grey) 
contains 11 transmembrane helices, forming the calcium channel and calcium binding sites. The 
nucleotide-binding domain (N, green) contains an ATP binding site near Phe 487 for ATP 
hydrolysis. The phosphorylation domain (P, blue) is autophosphorylated at Asp 351 during ATP 
hydrolysis. The actuator domain (A, red) facilitates structural transitions throughout SERCA 
during ATP hydrolysis for calcium transport. 
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ADP/ATP pocket formed by Phe 487, Lys 492, Lys 515, Thr 440, and Glu 442 [19]. 
 The catalytic cycle of SERCA is comprised of biochemical states with low (E2) 
and high (E1) calcium affinities, as well as phosphorylated (P) states (Fig. 3). Starting 
from the [Hn]E2-ATP state, two calcium ions bind to SERCA while protons from the 
previous cycle are expelled into the cytosol, forming the [Ca2]E1-ATP state. Subsequent 
ATP hydrolysis causes SERCA phosphorylation at Asp351, forming the [Ca2]E1P-ADP 
 
Fig. 3. SERCA enzymatic cycle. During its enzymatic cycle, SERCA binds calcium, transitioning 
from low calcium affinity E2 to the high calcium affinity E1. ATP is hydrolyzed and SERCA is 
autophosphorylated at Asp 351, reducing SERCA’s calcium affinity. Calcium is then released into 
the SR, ADP is released, and SERCA is dephosphorylated. Figure reprinted from [12]. 
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state and shifting the TM helices to occlude Ca from the cytosol. Release of ADP and 
binding of ATP forms the [Ca2]E2P-ATP state, where the TM helices open to the SR 
lumen. Now in a low-affinity calcium state, Ca is released from SERCA through the M 
domain into the SR in exchange for 2-3 protons ([Hn]E2P-ATP). Proton occlusion forms 
[Hn]E2-P-ATP, and subsequent release of the inorganic phosphate Pi (dephosphorylation) 
returns SERCA to the [Hn]E2-ATP state. 
 The structures corresponding to these biochemical states have slowly been 
determined, primarily by X-ray crystallography. The first high-resolution SERCA 
structure was determined by Chikashi Toyoshima and co-workers in the year 2000, using 
X-ray crystallography on crystals of SERCA in native SR in the calcium-bound state 
[20]. Subsequent work by Toyoshima, Poul Nissen, and others has crystallized SERCA in 
additional biochemical states, using calcium and inhibitors to stabilize those states. The 
end result is a high-resolution model for SERCA in each of its biochemical states, with 
the [Ca2]E2P-ATP state recently determined by Jones and co-workers (Fig. 3) [21]. 
 
1.4 PLB: The Regulatory Peptide 
 PLB is a regulatory peptide consisting of 52 residues and three structural domains 
(Fig. 4) [10]. Domain Ia (residues 1-16) is a dynamic amphipathic helix at and above the 
SR membrane. It is connected by a highly dynamic loop region (residues 17-22) to a 
transmembrane helix that extends above the SR membrane surface (domain Ib, residues 
23-30), and down to the bottom surface (domain II, residues 31-52). Domain Ib is also  
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dynamic, while domain II is restricted, exhibiting microsecond uniaxial rotational 
diffusion with minor nanosecond off-axial dynamics [23-26]. Domain Ia also contains 
three arginines, conferring +3 charge to PLB’s amphipathic helix. This is known to 
influence protein-protein interactions and dynamics [27]. Domains Ib and II are 
electrically neutral (zwitterionic), while PLB retains a total +3 charge from domain Ia. 













Fig. 4. PLB tense state high-resolution structure determined by hybrid NMR [22]. PLB is a single-
pass transmembrane regulatory peptide. Domain Ia (residues 1-16, red) is -helical and partially 
embedded in the SR membrane when PLB is in its ground state. An unstructured loop region 
(residues 17-22) connects domain Ia to domain Ib (residues 23-30), which is typically also -
helical. Domain II (residues 31-52) forms an -helix spanning the SR membrane. 
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greatest populated of these states include the monomer, a single protomer of PLB, and the 
pentamer, containing five protomers of PLB [28-30]. While the PLB monomer is the 
primary inhibitor of SERCA [31], the pentamer functions as a reservoir for PLB 
protomers in the system [30, 32, 33]. The pentamer is stabilized by a number of leucine 
and isoleucine residues in domain II, forming a leucine/isoleucine zipper between 
adjacent PLB protomers [34]. This pentamer is relatively stable, requiring high 
temperature to dissociate in sodium dodecyl sulfate (SDS) gel electrophoresis [29]. PLB 
was measured to equilibrate between the monomer and pentamer on a timescale slower 
than minutes by Förster Transfer Recovery (FTR) [35]. To simplify PLB structural 
measurements, the monomeric mutant Cys36Ala/Cys41Phe/Cys46Ala (AFA) PLB is 
used to destabilize oligomeric interactions, while maintaining similar SERCA inhibitory 
potency [36]. 
 An important post-translational modification to PLB is phosphorylation, where a 
phosphate group (PO4
3-
) is covalently attached to a residue [37, 38]. Phosphorylation can 
have dramatic effects on protein structure and dynamics, due to changes in electrostatics 
and hydrophobicity [39]. PLB is known to be phosphorylated at Ser16 by protein kinase 
A (PKA), and at Thr17 by Ca
2+
/calmodulin-dependent protein kinase II (CaMKII) [40]. 
These site-dependent modifications are proposed to have distinct functional effects on 
PLB [41, 42]. In addition to altering the dynamics of the amphipathic helix [23, 25], 
Ser16 phosphorylation shifts the monomer-pentamer equilibrium towards the pentamer 
[30, 43, 44], and reduces PLB inhibitory potential [37, 38] 
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 PLB also exists in several structural states, characterized primarily by the 
dynamics of the amphipathic helix (Fig. 5). In the rigid T state, the helix is partially 
embedded in the SR membrane, and is relatively immobile. In the contrasting R state, the 
helix is free above the SR membrane, and experiences large-amplitude nanosecond 
motion [25, 45, 46]. Partial unwinding of domains Ia and Ib are also observed in the R 
state, with relatively little change in domain II [26, 46, 47]. PLB is in equilibrium 
between the T and R states on the millisecond timescale [47]. Ser16 phosphorylation has 
been shown to shift the T-R equilibrium towards the R state [25, 45]. Recent NMR 
measurements by the Veglia laboratory suggest additional structural states, characterized 















R State PLB Phospho. PLB Pentameric PLB
 
Fig. 5. Structural and biochemical states of PLB. The unphosphorylated, monomeric, T-state PLB 
is referred as the ground state (top, center). From this ground state, it may exchange into the R 
state (bottom, left), become phosphorylated at Ser16/Thr17 (bottom, center), or self-oligomerize 
into a pentamer (bottom, right). These are three distinct transitions that may occur exclusively or 
concurrently. For example, complete PLB phosphorylation increases the R state and pentamer 
populations, though unphosphorylated R-state and pentameric PLBs still exist in the system. 
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for T and R, respectively, and are observed to increase in population with increasing 
temperature and S16 phosphorylation [48, 49]. 
 
1.5 The SERCA-PLB Complex 
 PLB was first proposed as a regulator of SERCA in the mid-1970s primarily by 
Arnold Katz and co-workers, resulting from observations of increased SERCA activity 
after PKA-induced phosphorylation of cardiac SR containing SERCA and PLB [50].  
 
Fig. 6. SERCA-PLB crystal structure (4KYT) [21]. Larry Jones and co-workers co-crystallized 
rabbit SERCA1a with a superinhibitory mutant PLB4 (N27A, N30C, L37A, V49G) with increased 
binding affinity for SERCA in the E2 state without bound calcium. The protein density 
corresponding to SERCA1a (blue) is consistent with previous high-resolution SERCA structures 
[11, 51]. Density proposed to correspond to the PLB TM helix (red) is consistent with cross-linking 
studies [52, 53]. Grey density is not well-understood, and may correspond to domain Ia of PLB or 
the TM helix of another protein. 
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Since then, the functional consequences of PLB binding to SERCA have been well-
elucidated [54, 55]. PLB reduces the apparent calcium affinity of SERCA, thereby 
inhibiting the rate of calcium transport across the SR membrane [56]. This inhibition can 
be relieved in two ways: (1) by additional calcium, which directly overcomes the 
reduction in calcium affinity, or (2) phosphorylation of PLB at Ser16 [38, 46]. While 
these effects are known functionally, the structural basis for their efficacy remains 
controversial. Cross-linking [57] and immunoprecipitation [51] experiments revealed a 
disruption in the SERCA’s M domain PLB binding groove (M2, M4, M6, and M9) after 
added calcium or Ser16 phosphorylation of PLB by PKA, as well as decreased binding 
affinity. These results suggested a model where additional calcium or PLB 
phosphorylation causes a dissociation of the SERCA-PLB complex (Dissociation Model, 
[58]), thus relieving the inhibitory effects of PLB on SERCA and restoring maximum 
calcium affinity and transport. However, numerous fluorescence spectroscopic studies 
[59, 60] observe no significant change in distance between SERCA and domain Ia of 
PLB after added calcium or PLB phosphorylation, suggesting that the complex is 
preserved. EPR dynamics measurements of PLB’s domain Ia in the presence of SERCA 
also find restricted motion after phosphorylation, suggesting a population where PLB 
remains bound to SERCA [25]. These observations are better explained by a model 
where additional calcium or PLB phosphorylation relieves inhibition by causing a subtle 
structural change within the SERCA-PLB complex, while PLB remains bound to SERCA 
as a subunit (Subunit Model). However, these spectroscopic measurements have not been 
made for PLB’s TM helix, the site of SERCA inhibition. 
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1.6 Physiological Relevance of the SERCA-PLB Complex 
 An important question to answer before launching into structural studies of the 
SERCA-PLB complex is, “Why is this research scientifically and socially relevant?” The 
answer is that understanding the structural mechanisms of calcium transport is essential 
for treating several debilitating conditions, including heart disease, muscular dystrophy, 
and diabetes. Fig. 8 shows data correlating decreased SERCA activity and SR calcium 
(likely due to inadequate SERCA function) with heart failure phenotypes [62, 63]. 
Studies in mice with muscular dystrophy (mdx) also demonstrate low SERCA activity 
and high cytosolic calcium [64, 65]. Obese and diabetic mice have insufficient SERCA, 

















Fig. 7. Scheme for SERCA and PLB homo/hetero-oligomerization. Both SERCA (blue) and PLB 
(red) form homo-oligomers (left). SERCA and PLB also bind together to form an inhibited hetero-
complex (center). This complex also forms its own homo-oligomers, further reducing SERCA 
activity. Phosphorylation of PLB in the SERCA-PLB restores activity, but the structural 
mechanism responsible for this relief of inhibition is not clear. In the proposed dissociation model, 
PLB phosphorylation causes dissociation of the complex (right, top). In the proposed subunit 
model, PLB phosphorylation causes a subtle structural change within the complex (right, bottom). 
Figure adapted from [61]. 
 
  13 
improves cardiac contractility in heart failure phenotype rats [68], reverses muscle 
degradation in mdx mice [69], and also improves cardiac contractility in diabetic mice 
[70]. 
 Roger Hajjar has led an effort to overexpress SERCA in humans by intracoronary 
infusion of an adeno-associated viral (AAV) vector containing SERCA2a DNA 
(MYDICAR) [71-74]. This AAV treatment has proven successful in delaying death in 
animal heart failure models (rodent, pig, and sheep), and is currently being tested in 
Phase 1 and 2 clinical trials in humans (CUPID), with positive initial results. One year 
after percutaneous intracoronary injection of MYDICAR, parameters of cardiac 
contractility such as ejection fraction and VO2 max are increased, with decreased 


















































Fig. 8. Impact of heart failure on calcium transport. (a) SERCA activity measurement by 
pyruvate/NADH coupled enzyme assay and (b) SR calcium content measurement by calcium-
binding fura-2 fluorescence on human left ventricle SR samples collected from healthy (control) 
and heart failure (failing, ischemic cardiomyopathy and dilated cardiomyopathy) patients. Heart 
failure patients demonstrate lower ATPase activity and lower SR [Ca], indicative of insufficient 
SERCA activity. Figures adapted from [62] and [63]. 
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of this method, a number of limitations are clear. Approximately 80% of adults exhibit 
immune response of varying intensity to the AAV vector [75], AAV vector may only be 
administered once per person due to development of AAV-specific antibodies [71], and 
while it is injected directly into the heart, it diffuses to other organs including the liver 
and spleen [76]. 
 An alternative to overexpressing SERCA is to directly activate endogenous 
SERCA. This is more difficult than overexpression because subtle and precise structural 
perturbation is required to force SERCA into an active conformation. In general, this 
requires further understanding of the structure-function relationship for the SERCA-PLB 
complex through its enzymatic cycle. This is well-developed for SERCA alone (see Fig. 
3), but not for the SERCA-PLB complex. High-resolution crystal structures of the 
SERCA-PLB complex have begun to emerge, and they have been invaluable in 
hypothesizing the structural basis for SERCA inhibition, particularly for the PLB TM 
helix. However, crystal structures are often acquired under several non-physiological 
conditions: in detergent or non-native lipid, frozen at low temperature and lacking 
intrinsic dynamics that plays a role in function, or bound to inhibitors that perturb 
structure. Additionally, they often fail to resolve protein segments with considerable 
dynamics, such as PLB’s amphipathic helix (domain Ia). Detailed structural studies of the 
SERCA-PLB complex at physiological conditions are needed to complete the model 
begun by crystal structures of the SERCA-PLB complex structure-function relationship 
as it exists in live cells. 
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 What methods do we have available for activating SERCA? Fig. 9 shows several 
different schemes to activate SERCA. One direct method is to remove PLB from the SR 
(ablation), thus eliminating its inhibitory effect on SERCA. This has been done by 
knocking out the gene responsible for PLB expression in mice and human models. While 
increased SR calcium and increased cardiac contractility were measured in isolated mice 
and human myocytes [77], mice subjects still suffered from heart failure [78, 79]. 
Additionally, ablation of PLB removes cardiac muscle regulation by -adrenergic 
stimulation, rendering the heart unable to respond to stress-induced adrenaline [77]. 
 A less drastic alternative to PLB ablation is reduction of PLB inhibitory potential 









Fig. 9. Schemes for SERCA activation. The physiological method of activation is phosphorylation 
of PLB (left) during adrenaline response. PLB could also be ablated from the system (mid-left). A 
small molecule drug could stabilize a non-inhibitory conformation of PLB on SERCA (mid-right). 
Also, a PLB mutant with similar binding affinity but reduced inhibitory potency could be introduced 
(right). 
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SERCA such that it can compete with endogenous wild-type SERCA, but adopts an 
alternate, less inhibitory, conformation upon SERCA [26, 60, 80]. Several PLB mutations 
have been characterized, including the superinhibitory and lethal Arg9Cys [81, 82], the 
phosphomimetic Ser16Glu [82, 83], and the monomeric Cys36Ala/Cys41Phe/Cys46Ala 
(AFA) [36]. Notably, work by the Veglia lab has demonstrated correlation between 
inhibitory potential, binding affinity, and dynamics using nuclear magnetic resonance 
(NMR) on PLB with mutations at positions 16 and 21 in the cytoplasmic helix and loop 
regions respectively [82]. 
 Another method is to use a small molecule (drug) with affinity for the SERCA-
PLB binding interface to allosterically alter the SERCA-PLB conformation to a less 
inhibitory structure. This could be accomplished through perturbation of the structure of 
SERCA or PLB within the complex, and similar to the previous method, should not 
significantly alter the binding affinity of PLB. To discover these small molecule drugs, 
broad-range screening experiments are performed using pre-existing drug libraries. These 
screening experiments test hundreds of small molecules quickly, in order to identify those 
that perturb protein structure, called ‘hits’. Preliminary pilot studies using fluorescence 
resonance energy transfer (FRET) between SERCA and PLB (IAEDANS-SERCA and 
DABCYL-PLB) [84] and within SERCA (RFP-GFP-SERCA) [85] have identified 
several compounds that alter SERCA-PLB structure, including CDN1001, CDN1033, 
CDN1134, and CDN1163. Subsequent experiments further characterize these hits 
through detailed functional and structural studies, in order to elucidate the mechanism of 
these small molecules (unpublished results and in-progress studies by the Thomas lab). 
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Additionally, chemical engineers are currently designing derivatives in the hopes of 
obtaining a small molecule with higher efficacy [84, 85]. 
 
1.7 Thesis Outline and Significance 
 The primary aim of my thesis work is to determine the structural basis for SERCA 
regulation by PLB, including inhibition and phosphorylation-induced relief of inhibition 
(see Fig. 7). This is to support the therapeutic treatments described in the previous 
section, with particular emphasis on PLB mutants and small molecule drugs, which aim 
to perturb SERCA-PLB structure towards an active conformation. While it is true that 
effective mutants and drugs can be discovered without a structural basis, this structural 
information will make targeted research possible, expediting development and leading to 
treatments with higher efficacy and specificity. In my work, I probe the conformation of 
PLB within the active and inactive SERCA-PLB complex using EPR spectroscopy, 
which I will demonstrate in Chapter 2, is an excellent tool to measure protein structure 
and dynamics under physiological conditions. 
 The first goal of my thesis work was to resolve the structural effect of Ser16 PLB 
phosphorylation on the SERCA-PLB complex, in terms of the competing Dissociation 
and Subunit models (Chapter 3). Finding strong evidence to support the Subunit Model, I 
continued to further probe the structural mechanism of SERCA inhibition relief by PLB 
phosphorylation. To do so, I optimized a reconstitution system (bicelles) in which I could 
study changes in protein orientation at physiological conditions (Chapter 4). I 
implemented this system to measure PLB topology using a bifunctional spin label (BSL), 
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which was corroborated by molecular dynamics simulations (Chapter 5). Having 
validated the technique, I then pursued measurements of PLB topology in the presence of 
SERCA, which is an ongoing study (Chapter 6). In Chapter 7, I summarize the main 
conclusions of my thesis work, and outline future studies that follow from the research 
presented here. 
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Chapter 2: Electron Paramagnetic Resonance 
 
2.1 Electron Spin Label and Site-Directed Spin Labeling 
 Electron Paramagnetic Resonance (EPR) is a spectroscopic experiment designed 
to measure the local environment, structure, and dynamics of molecules and proteins 
through a free radical (unpaired electron). With the exception of metal complexes and a 
few other compounds, most molecules lack an unpaired electron. To perform EPR 
(a)                                (b)                         (c)
(d)                                          (e)
 
Fig. 10. Common EPR spin labels for site-directed spin labeling. The maleimide spin label (a), 
methanethiosulfonate spin label (MTSL, b), and iodoacetamide spin label (IASL, c) all attach 
monofunctionally to the sulfhydryl group on a single cysteine. The 2,2,6,6-tetramethyl-N-oxyl-4-
amino-4-carboxylic acid spin label (TOAC, d) is directly incorporated as a synthetic amino acid 
within a protein’s sequence, while the 3,4-bis-(methanethiosulfonyl-methyl)-2,2,5,5-tetramethyl-
2,5-dihydro-1h-pyrrol-1-yloxy spin label (BSL, e) attaches to two free cysteines by disulfide 
bonding. 
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experiments on these species, a spin label containing an unpaired electron can be attached 
to the molecule (Fig. 10). Most electron spin labels are comprised of a five or six 
membered aromatic ring, with a nitroxide bond containing the unpaired electron in a p 
orbital. Methyl groups stabilize the nitroxide bond, while atoms on the other side of the 
aromatic ring accommodate attachment to the protein. 
 There are several ways to attach spin labels to proteins [86]. The most common 
method is attachment to a single cysteine residue (monofunctional spin label). Cysteines 
contain a sulfhydryl group (SH) that can react with double bonds within aromatic rings 
(C=C, maleimide, Fig. 10a), a sulfonyl group (SO2CH3, methanethiosulfonate, Fig. 10b) 
or an iodo group (I, iodoacetamide, Fig. 10c). The reacted cysteine may be endogenous, 
or mutated into the protein sequence. The process of attaching a spin label to a specific 
residue on a protein is called site-directed spin labeling (SDSL) [87]. Cysteine is a 
relatively uncommon amino acid, so there is typically little to no problem with 
specificity. However, with site-directed mutagenesis, cysteines can be mutated into a 
protein sequence, or native cysteines can be mutated out, prior to protein expression in 
cells. However, choosing a suitable location can be problematic, since protein structure 
and function must be preserved. Monofunctional attachment is common because it 
requires only a single cysteine, and thus is less likely to significantly affect the protein. 
Its primary limitation is the length and flexibility of the linker segment attaching the spin 
label to the host protein. These perturbations in distance and motion can complicate 
measurements of protein structure and dynamics; however this is not always the case, and 
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is typically site-dependent. Many studies have utilized monofunctional spin labels with 
excellent success [87-89]. 
 Another method involves attachment to two cysteine residues (bifunctional spin 
label). This class of spin label was developed by Toshiaki Arata and co-workers, as a way 
to restrict the label dynamics often encountered with monofunctional spin labels [90]. 
The bifunctional spin label is best attached on a segment of protein with rigid backbone 
dynamics, such as an alpha helix, where the periodic structure facilitates attachment at 
two specific residues (residue i and i+4, for example) (Fig. 10d) [91]. In contrast to a 
monofunctional spin label, a bifunctional spin label is substantially immobilized [92, 93], 
though its linker does introduce some distance perturbations. Additionally, optimizing the 
chemical reaction to obtain homogeneous bifunctional attachment (as opposed to partial 
monofunctional attachment, or protein cross-linking) requires substantial effort [94, 95], 
and is not possible for all proteins. 
 The last method incorporates the spin label as a synthetic amino acid into the 
protein structure. This technique was developed by Clovis Nakaie as a way to directly 
couple a spin label into the peptide backbone [96]. The 2,2,6,6-tetramethyl-N-oxyl-4-
amino-4-carboxylic acid (TOAC) attaches with an amine group and carboxylic acid on 
the alpha carbon of the aromatic ring, similar to a natural amino acid (Fig. 10e). This 
results in a spin label which is rigidly bound to the protein and contains essentially no 
linker region, making it ideal for protein measurements [23, 97]. The primary limitation 
with a synthetic spin label like TOAC is that the protein must be synthesized and the spin 
label inserted during synthesis, typically using a method called solid-phase peptide 
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synthesis (SPPS). This technique requires extensive optimization, and is applicable only 
to proteins with ~50 residues or less [98]. 
 
2.2 The Zeeman Effect 
 The origin of the EPR measurement is the Zeeman Effect, an atomic interaction 
discovered by Pieter Zeeman and characterized by Hendrik Lorentz in 1897 [99]. Zeeman 
placed a Bunsen burner within a magnetic field produced by an electromagnet, and 
observed the emission lines of sodium chloride change wavelength as a function of 
magnetic field strength. With the assistance of Lorentz, he proposed that as ions from the 
salt were released from combustion, they experienced force from the magnetic field, 
altering their vibration and thus their emission wavelength. The force F on a molecule 
with magnetic dipole moment  in a magnetic field H is: 
  ⃗    ⃗⃗( ⃑   ⃗⃗) Eq. 1 
The net energy resulting from the force in Eq. 1 is thus: 
    ∫  ⃗    ⃗    ⃑   ⃗⃗ Eq. 2 
In EPR, our molecule of interest is an unpaired electron. Its magnetic moment is 
generated by its spin, an intrinsic quantum mechanical property. This spin does not 
correspond to actual movement of charge (if it did, the electron would have to rotate at a 
velocity faster than light [100]), but is a property similar to mass or electric charge. The 
electron has a spin quantum number s = ½. Its total spin angular momentum S is then 
given by: 
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   √          Eq. 3 
where ħ is the reduced Planck constant (ħ = h / 2π), and h is Planck’s constant. Therefore, 
for the electron with spin ½, its total spin angular momentum is √     . Its spin angular 
momentum in any single direction is given by: 
         Eq. 4 
where ms is the secondary spin quantum number. Therefore, for the electron with spin ½, 
Sz = ± ħ/2. The reason that |Sz| < S is due to the uncertainty principle, which places a 
lower limit on the spin angular momenta in the x and y directions [100]. Generally, we 
choose the z direction to coincide with our experimental setup, such as the magnetic field 
direction. From this result, we can calculate the electron magnetic moment due to its spin 
angular momentum: 
         
  
 
 Eq. 5 
where g is the electron’s spin g factor, relating its magnetic moment to its spin angular 
momentum, and  is the Bohr magneton. Therefore, for the electron, z = ± g· / 2. 
Combining this result with Eq. 2, we obtain: 
      
 
 
       Eq. 6 
where H is now the magnitude of  ⃗⃗ defined along the z direction (the applied magnetic 
field strength). From Eq. 6, we see that the unpaired electron can occupy one of two 
energy levels. The difference in energy is given in Eq. 7: 
                Eq. 7 
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It is the energy structure in Eq. 7 that allows us to perform EPR spectroscopy, using 
photons of energy h (where  is the radiation frequency) to excite spin transitions from 
the lower (ground) to the upper (excited) electron spin states, and to stimulate spin 
transitions from the excited to ground state (Fig. 11). When the supplied radiation 
possesses the correct energy to excite these transitions, the system is in resonance. This 
condition is specified by the resonance equation obtained from setting Eq. 7 equal to h: 
       
      
   










Fig. 11. The Zeeman effect. An unpaired electron has two spin states (ms = ± ½). In the absence 
of a magnetic field (left), there is no difference in energy between ms = +½ and ms = -½. However, 
when a magnetic field is applied, the Zeeman effect breaks the energy degeneracy between 
these two states, such that E(+½) is greater than E(-½). The difference in energy is proportional 
to the magnetic field strength (see Eq. 7). 
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where HRES and RES correspond to the magnetic field strength and radiation frequency, 
respectively, required to achieve resonance. In theory, either may be varied to achieve 
resonance, though in practice, the radiation frequency is held constant while the magnetic 
field is varied [101]. The populations of electrons in the ground and excited states are 




    (
   
   
) Eq. 9 
where EXP(x) is the exponential function (e
x
). At Boltzmann equilibrium, there is always 
an excess population in the ground state. For spectroscopy in general, this excess 
population is very small (NEPR ~ 0.15%, NNMR ~ 0.01%). The ground state population 
excess allows for radiation to promote electrons to the excited state. This radiation shifts 
the spin system away from Boltzmann equilibrium, and if it is sufficiently intense, can 
eliminate the excess population in the ground state. When this occurs, the spin system is 
saturated, and can no longer absorb radiation. Electrons in the excited state will naturally 
relax back to the ground state by T1 (spin-lattice) relaxation, a process where excited state 
















   
)     (
  
  
) Eq. 10 
where t corresponds to time t, EQ corresponds to Boltzmann equilibrium, and SAT 
corresponds to the change in population induced by radiation. Most conventional EPR 
experiments are done in the absence of significant saturation; however there are 
exceptions (see Section 2.6). In addition to T1 relaxation, there is also T2 relaxation (spin-
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spin), involving the exchange of spin states between two electrons. Since there is no net 
energy change due to T2, it does not contribute to saturation. However it does contribute 
to spin coherence, and affects the ensemble of spin states. Thus, T2 is entropic relaxation, 
while T1 is enthalpic relaxation. 
 
2.3 The EPR Spectrometer 
 A conventional EPR spectrometer consists of four primary components: the 



































Fig. 12. Diagram of a continuous wave EPR spectrometer. Microwaves are produced at the 
source by a Gunn diode (left), traveling through the waveguide to the resonator (center) where 
they produce a standing wave across the sample (dotted blue). As microwaves are absorbed by 
the sample, others are reflected from the resonator back up the waveguide to the detector (right). 
The electromagnet sweeps the magnetic field strength, while the modulation coils within the 
resonator generate an oscillating magnetic field, allowing for derivative absorption detection and 
phase-sensitive detection. 
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Within the microwave source, microwaves are generated by a Gunn diode. In it, electrons 
are accelerated from anode to cathode through semiconductor material, acquiring 
sufficient kinetic energy to reach an energy band above the conduction band. Relaxation 
from this band generates microwave radiation [102]. These microwaves are directed via 
waveguides to two components: (1) the microwave detector, to keep it in its linear 
operating regime (bias level), and (2) the resonator, a metal cavity designed to expose the 
sample to standing microwaves (~mW power). The sample containing unpaired electrons 
will absorb some microwaves, causing a change in the microwave power reflected back 
from the resonator. These reflected microwaves travel back through the waveguide, and 
to the detector diode (Schottky) within the microwave bridge, where they are rectified 
into an electrical signal. During the EPR experiment, an electromagnet generates a 
magnetic field at the sample. This field is swept from low to high strength (~ 3300 G to 
3400 G for nitroxide spin labels at X-band microwave radiation), with superimposed field 
modulation (~1 G amplitude at 100 kHz frequency for conventional EPR). The magnetic 
field modulation allows detection of derivative microwave absorption, enhancing EPR 
spectral lineshape sensitivity, and enabling phase-sensitive detection, where all signals 
not matching the modulation frequency are rejected before post-acquisition processing. 
 
2.4 Hyperfine Interaction 
 The resonance equation (Eq. 8) demonstrates that absorption and emission will 
occur for a specific magnetic field strength and radiation frequency. In practice, the 
radiation frequency is completely defined by the microwave source used in the 
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experimental setup. However, the magnetic field strength is not completely defined by 
the electromagnet; there are several magnetic field sources within the sample itself. The  
source that typically exerts the strongest field on the unpaired electron is the nitrogen 
nucleus within the nitroxide bond of the spin label. 
14
N accounts for 99.64% of naturally 
occurring nitrogen, and possesses a nuclear spin of I = 1. Therefore, it may adopt a spin 
state of mI = -1, 0, or +1 along the axis of the external magnetic field, generating an 
additional magnetic field that can increase or decrease the total magnetic field 












(b)                                    (c) 2T||′
 
Fig. 13. The hyperfine interaction. (a) In addition to the Zeeman interaction breaking the spin 
degeneracy (Fig. 11), the hyperfine interaction splits the spin energy levels further, such that 
three spin transitions are possible (purple, right). The nitrogen nucleus within the electron spin 
label generates a magnetic field (blue) experienced by the unpaired electron (red) in addition to 
the external magnetic field (green) (b). The three spin transitions (purple) lead to the typical 
nitroxide spectrum, with three lines separated by 2T||′ (c). 
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field with the unpaired electron is called the hyperfine interaction, and further splits the 
two-state system caused by the Zeeman interaction (Fig. 11) into a six-state system (Fig. 
13). Quantum selection rules state that the nitrogen nuclear spin cannot change during an 
electron transition, resulting in three unique resonances (Fig. 13). Therefore, the 
resonance equation (Eq. 8) can be rewritten to reflect the dependence on nitrogen nuclear 
spin: 
       
      
   
      Eq. 11 
where mI is the nitrogen secondary spin quantum number, and T is the hyperfine splitting 
constant. Since there are three possible values for mI (-1, 0, +1), there are three possible 
values for HRES, resulting in the typical nitroxide three line spectrum (Fig. 13c). 
 
2.5 Orientation Sensitivity 
 As the unpaired electron’s p orbital within the spin label is anisotropic, it defines 
a coordinate system called the probe frame (Fig. 14). Within this frame, the nitrogen p 
orbital is along the z direction, and the nitroxide bond is along the x direction. This probe 
frame is relevant because the direction of the magnetic field within the frame alters the 
resonance condition (Eq. 11). That is, both the electron g tensor and the hyperfine tensor 
are anisotropic. Defining the magnetic field direction in the probe frame using the 
spherical angles  (polar) and  (azimuthal): 
            
      
        
           Eq. 12 
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Thus, Eq. 12 shows that the effective g and T values that define magnetic resonance 
depend upon the magnetic field direction (,), as shown in Fig. 15. These dependencies 
are shown in Eq. 13 and Eq. 14: 
              
              
              
   Eq. 13 
        [   
              
              
      ]
   
 Eq. 14 
Since g and T have different dependencies on the spherical angles  and , there is no 






















Fig. 14. EPR coordinate systems. The most common reference frame is the probe frame (left), 
defined by the spin label. The z axis is parallel to the p orbital containing the unpaired electron 
(cyan with red dot), while the x axis is parallel to the nitroxide bond (N-O). The magnetic field H is 
then described as a vector within this frame by the polar angle  and the azimuthal angle . 
Another common frame is the lab frame (right), where the magnetic field defines the z axis. In this 
frame, the label principal axis (zP) is described by the angles A and A. 
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 Eq. 15 
     
        
 
 Eq. 16 
As such, EPR does not have the orientational ambiguity of fluorescence measurements, 
which yield isotropic values for the magic angle of  ≈ 54.7o (Fig. 15) [103]. This makes 
EPR well-suited for measuring orientation distributions of spin labels, provided the 
experiment is done on a well-ordered system. This involves choosing relatively immobile 
residues on proteins, and choosing an anisotropic protein environment with a well-
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Fig. 15. EPR orientation dependence. Both the center (electron g) and splitting (hyperfine T) of 
the EPR spectrum are sensitive to the orientation of the label relative to the magnetic field. See 
also Eq. 13 and Eq. 14 for calculation of the effective g and T values. 
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2.6 Rotational Diffusion Sensitivity 
 As a result of its sensitivity to orientation, EPR is also sensitive to rotational 
diffusion, which typically occurs as Brownian motion. In characterizing rotational 
diffusion, we refer both to the rate and amplitude of motion (Fig. 16). The rate of 
rotational diffusion is described by the diffusion rate constant DR. This can be estimated 
with the Stokes-Einstein formula, which for a globular protein takes the form: 
     
   
       
  Eq. 17 
where kBT is the thermal Boltzmann factor,  is the surrounding viscosity, and r is the 
protein radius. For membrane-bound proteins with a cylindrical transmembrane region, 
Eq. 17 takes the form: 
     
   
         
  Eq. 18 
where h is the height of the membrane. From the diffusion rate constant, we can define 
another common parameter called the rotational correlation time: R. The rotational 
correlation time is related to the diffusion constant by Eq. 19: 
     
 
    
  Eq. 19 
R is the time required for the protein to diffusion one radian in a given direction. For 
proteins free in solution, R ~ ns, while for proteins embedded in membrane, R ~ s. 
 In addition to the rate of rotational diffusion as characterized by R, the amplitude 
of rotational diffusion can be characterized by the order parameter S: 
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              Eq. 20 
where  is the angle between an axis upon the object (such as the spin label’s principal 
axis) and the sample’s symmetry axis (lipid bilayer normal, muscle fiber axis, etc). For a 
low value of S (~ 0), <cos
2> ~ 1/3, indicating an isotropic distribution for , and 
isotropic rotational diffusion. For a high value of S (~ 1), <cos
2> ~ 1, indicating singular 







Fig. 16. Rate and amplitude of rotational diffusion. The rate of rotation diffusion describes the 
spin label’s (zP) change in angular displacement () as a function of time. This is typically referred 
to by the correlation time R. The amplitude of rotational diffusion describes the spin label’s 
maximum angular displacement (C) over its entire trajectory. Often this is referred to by a cone 
angle, but this is one of several model-dependent interpretations for anisotropy. 
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calculated directly from spectral measurements, as shown in Eq. 21: 
   
                   
                  
 
   
    
      
  Eq. 21 
where T||′ is the splitting for the sample of interest (intermediate splitting), T0 is the 
splitting for the sample undergoing rapid, isotropic rotational diffusion (minimum 
splitting), and T|| is the splitting for the sample under full immobilization with an 
isotropic orientation distribution (maximum splitting) (see also Fig. 13). 
 Briefly, rotational diffusion can be considered as exchange of different orientation 
states. Indeed, an EPR spectrum containing all orientation states as static (powder) is 
much different than an EPR spectrum containing all orientation states with dynamic 





















wres = (g / )·(H + mIT)
1/ex = exchange rate
w ~ GHz for nitroxide
 
Fig. 17. Chemical exchange between orientation states. For a simple system with two orientation 
states, there are two resonance points, at wA and wB. At the slow limit, where there is very little 
rotational diffusion of the sample and no exchange (1/ex) between these two states, resonance 
occurs only at wA and wB. As the rate of rotational diffusion increases (relative to the difference 
between wA and wB), the resonance points begin to broaden and shift position, until at the fast 
limit (where the exchange rate is much greater than the difference between wA and wB), the two 
orientation states are no longer distinct, and instead we observe a single averaged resonance 
point. 
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both the positions (motional narrowing) and widths (linewidth broadening) of the 
resonance lines (Fig. 17). Rotational diffusion on the order of T2, the transverse 
relaxation parameter related to resonance linewidth, will cause motional narrowing and 
linewidth broadening. Thus, conventional EPR is sensitive to rotational diffusion when ps 
< R < s (Fig. 18, left). 
 For rotational diffusion slower than microseconds, the conventional EPR 
spectrum is at the rigid limit, and loses sensitivity to changes in rotational diffusion. 















Fig. 18. EPR spectral sensitivity to rotational diffusion. Conventional EPR relies on T2 relaxation 
for spectral resolution, so it has sensitivity to rotational diffusion on the order of T2 (R ~ ps to ns). 
Rotational diffusion slower than this is at the slow limit for conventional EPR, and no longer can 
affect the spectrum. In contrast, saturation transfer (ST) EPR relies on T1 relaxation, so it does 
have sensitivity to slow rotational diffusion (R ~ s to ms). When used together, conventional and 
saturation transfer EPR can measure a broad range of dynamics. 
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PLB and SERCA. To detect this diffusion, we can use a technique called saturation 
transfer EPR. In contrast to a conventional EPR experiment, saturation transfer EPR uses 
high microwave power (~20 mW) to induce significant saturation in the sample, 
perturbing it from Boltzmann equilibrium. The equilibrium is restored by enthalpic T1 
relaxation, where T1 ~ 10 s. However, rotational diffusion on the order of T1 also 
contributes to the apparent relaxation rate. The rotational diffusion causes saturation to 
diffuse to other positions in the spectrum (orientations), relieving the saturation induced 
at the instantaneous spectral position in the experiment, but not of the entire sample (as 
only T1 relaxation will truly relieve saturation). As a result, rotational diffusion where ps 
< R < ms can be resolved by saturation transfer EPR (Fig. 18, right). In order to enhance 
sensitivity to this slow rotational diffusion, microwave radiation that is 90
o
 out of phase 
with the magnetic field modulation (which is reduced from 100 kHz to 50 kHz) is 
selectively detected, making the signal intensity lower than that of conventional EPR. 
Thus, conventional EPR is traditionally used for ps < R < s and saturation transfer EPR 
is traditionally used for s < R < ms (Fig. 18). 
 
2.7 Anisotropic Membrane Systems 
 Measuring the orientation distribution of a spin label attached to a protein requires 
that the protein be uniformly oriented with respect to a well-defined axis, such as the 
external magnetic field. In the case of membrane proteins, they must be reconstituted in a 
different membrane system, as lipid vesicles contain the membrane protein in many 
different orientations. The ideal environment is an extended, flat patch of lipid bilayer, 
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which is as similar to the native environment as possible without any membrane 
curvature. 
 The most straightforward anisotropic membrane is a substrate-supported lipid 
bilayer. In this technique, lipids are deposited onto a substrate such as metal or glass, and 
carefully rehydrated under high humidity to gradually build lipid bilayers upon the 
substrate. Typically, multiple layers parallel to the substrate surface are obtained, 
producing an anisotropic membrane. This method is advantageous in that essentially any 
combination of lipids can be used, such that the protein can be reconstituted in a native-
mimicking bilayer. However, the rehydration technique is not amenable to proper 
complex protein folding, and calls into question whether the environment is completely 
rehydrated. 
 Another popular anisotropic membrane is a bilayered micelle, or bicelle. A bicelle 
is a disc-like lipid structure with a flat patch of long chain (LC) lipid bilayer, and a rim of 
short chain (SC) lipids to protect the hydrophobic core of the bicelle. Bicelle  
Isotropic Lipid             Anisotropic Lipid
 
Fig. 19. Isotropic vs anisotropic lipid environments. Proteins (red) are typically reconstituted in 
isotropic lipid environments like micelles or vesicles (left), resulting in an isotropic protein 
orientation distribution. In contrast, an anisotropic lipid environment like a substrate-supported 
bilayer or bicelle (right) results in an anisotropic protein orientation distribution, suitable for protein 
topology measurements. 
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characteristics can be altered by the molar ratio of LC lipid to SC lipid (q ≡ [LC] / [SC]); 
for a bicelle of q ~ 3, its diameter is approximately 30 nm. In an isotropic solution, 
bicelles freely tumble and function much like vesicles. Due to the regular ordering of the 
lipid headgroups in the LC lipid bilayer, they possess negative total magnetic 
susceptibility, and thus can be uniformly aligned in a magnetic field. This magnetic 
susceptibility can be altered by lanthanide, which chelates to the lipid headgroups and 
increases or decreases the magnetic susceptibility. This allows alignment of the bicelles 
with their membrane normal either parallel or perpendicular to the magnetic field axis. 



























Fig. 20. Oriented bicelle EPR. Spectra of the lipid spin label 5-DOXYL-stearic acid (5-DSA) in 
bicelles with their membrane normal aligned randomly, parallel, or perpendicular to the 
spectrometer magnetic field. Substantial changes in lineshape occur based on orientation. 
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influences the phases of both the constitutive lipids and the bicelles as macromolecules in 
solution. Above the isotropic phase where bicelles exist as disc-like structures, they begin 
to fuse together in the nematic and smectic phases, forming large sheets of LC lipid with 
pores lined by SC lipid. This is commonly referred to as the “Swiss-cheese model”. 
 When spin-labeled proteins are reconstituted in bicelles, the changes in EPR 
spectra due to alignment are quite distinctive. Fig. 20 shows EPR spectra of the 5-
DOXYL-stearic acid lipid spin label in bicelles that are randomly oriented (top), aligned 
with their membrane normal parallel to the instrument magnetic field (middle) and 
perpendicular to the magnetic field (bottom). There are substantial changes in splitting, 
which can be measured to calculate the Euler angles between the spin label’s principal 
axis and the membrane normal: 
    
  [   
           
        ]
   
  Eq. 22 
where T||′ is the half width of the EPR spectrum, T|| and T┴ are the parallel and 
perpendicular hyperfine tensor values, and D is the angle between the spin label’s 
principal axis and the principal diffusion axis (typically taken to be the membrane 
normal) [104]. An equivalent and perhaps more integrated approach is to determine D 
through direct simulation of the experimental EPR spectra (see Section 2.9). This method 
also has the distinct advantage of accounting for protein wobble through variation of the 
order parameter S, which both improves fit convergence and provides greater detail on 
the orientation distribution of the protein. 
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2.8 Multifrequency EPR 
 The most common experimental setup for continuous wave EPR is to use 
microwave radiation frequency of ~9.5 GHz with a magnetic field strength of ~3500 G 
(X-band). However, Eq. 11 indicates that many combinations of radiation frequency and 
magnetic field strength will allow for resonance. Indeed, early EPR experiments used 
frequencies and field strengths ten times less than these [105]. Using higher frequencies 
and field strengths often affords greater spectral resolution and sensitivity [106], however 
there are technical limitations in terms of resonator composition and standing wave 
quality that impact its usefulness. These problems are gradually being overcome, with Q-
band (35 GHz) and W-band (95 GHz) measurements becoming more accessible [107, 
108]. 
 The difference in resolution is apparent from EPR spectra acquired at different 
frequency bands (Fig. 21). While the spectral spitting defined by T|| is relatively 
unaffected by radiation frequency, the central resonance position as defined by the 
electron g factor becomes more sensitive to spin probe orientation with increasing 
radiation frequency. This can be understood by the resonance equation (Eq. 12). The first 
term in Eq. 12, which defines the EPR spectrum’s central resonance position, is linearly 
dependent on radiation frequency. In contrast, the second term, which defines the low and 
high field resonance positions, is independent of radiation frequency. The end result is 
that at higher radiation frequency, EPR spectra corresponding to different probe 
orientations overlap less, such that g and T can be determined with greater accuracy.  
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2.9 EPR Data Analysis 
 EPR spectra can be analyzed in several different ways, depending on the type of 
experiment and conclusions desired. The most qualitative analysis involves noting 
general changes in EPR lineshape, indicative of some structural transition taking place in 
the sample. While this is useful during acquisition to verify sample preparation and 
compare previous hypotheses, more rigorous analysis is certainly possible (Fig. 22). 
X-Band W-Band







100G wide 200G wide 300G wide
 
Fig. 21. Multifrequency EPR. Simulated spectra of a typical nitroxide label with magnetic field 
oriented along the label’s x (red), y (blue), and z (green) axis, along with isotropic orientation 
(black) at X, Q, and W microwave frequency bands. As the microwave frequency is increased, 
the oriented components overlap less and less. This is also observed by the increasing 
complexity (number of lines) in the powder spectrum (bottom). Therefore, higher frequency bands 
possess greater orientation sensitivity. 
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 Measuring the distance in magnetic field units between the low and high 
resonance lines (splitting) is a way to calculate spin label mobility, as an increase in the 
rate of rotational diffusion will cause this splitting to decrease: 
           
     [     
     ]
     
  Eq. 23 
where T||′ is the splitting for the sample of interest, and T|| is the splitting of an 
immobilized version of the sample. Eq. 23 is an empirical formula valid for spin-labeled 
proteins exhibiting slow, restricted motion [109]. 
 Also of interest is the width of the resonance lines (linewidth), although unlike the 





















Fig. 22. EPR spectrum lineshape measurements. A conventional EPR spectrum is typically 
characterized by the splitting between the low and high field resonances (2T||’) and the linewidth 
of the low field resonance (2L’). These measurements can be used to determine rotational 
mobility and spin-spin interactions. 
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diffusion and presence of neighboring spin labels via spin-spin interaction. In the case of 
dilute spin label, an equation similar to Eq. 23 can be used in conjunction with the 
linewidth (as measured from the low field resonance line as half width at half maximum 
L′): 
            
    [    
    ]
        Eq. 24 
where again, the primed quantity refers to the sample as perturbed by rotational diffusion, 
and the unprimed quantity refers to the immobilized sample. Eq. 24 is valid for slow, 
restricted motion as well, although Eq. 23 is typically used instead of Eq. 24, due to 
possible effects from spin-spin interactions. 
 Determining the order parameter S from EPR spectra is commonly accomplished 
using Eq. 21, assuming the protein undergoes rapid restricted motion [110]. The spectral 
splitting corresponding to the protein sample of interest (2T||′), a fully immobilized 
protein sample (2T||), and a rapid isotropic protein sample (2T0) are required, so typically 
multiple samples of the same protein must be prepared. Freezing or lyophilizing the 
protein can be used to obtain T||′, while heating or truncating the protein in solution can 
be used to obtain T0. 
 Saturation transfer EPR spectra are analyzed based on peak height ratios and 
integrated intensity. These have been measured previously for spin-labeled hemoglobin, a 
well-characterized globular protein with a known rotational correlation time based on the 
Stokes-Einstein formula (Eq. 17) [111]. This spin-labeled hemoglobin was mixed into 
solutions containing a specific amount of glycerol to produce a desired viscosity, and thus 
a variety of rotational correlation times. The peak height ratios were measured from the 
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saturation transfer EPR spectra, and plotted against the calculated rotational correlation 
times. Using these plots, a sample with an unknown rotational correlation time can be 
determined from the peak height ratios or the integrated intensity measured from the 
saturation transfer EPR spectrum. The integrated intensity parameter is commonly used 
in STEPR analysis, due to its minimal sensitivity to orientation anisotropy and well-
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Fig. 23. Measuring rotational diffusion from saturation transfer EPR. STEPR spectra are analyzed 
by measuring intensities at specific locations in the spectrum (red, top left) or the integral of the 
spectrum (integrated intensity, IST). These values are then compared to correlation time plots 
obtained with standard samples of maleimide spin labeled hemoglobin in glycerol to determine 
the rotational correlation time for the sample of interest. Figures adapted from [111]. 
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 Precisely determining the rate and amplitude of rotational diffusion, as well as 
orientation distributions, requires analysis of EPR spectra beyond lineshape 
measurements. In these cases, we can fit EPR spectra through least-squares minimization 
and spectral simulation [113]. For a rigid limit (R > 100 ns) sample containing one or 
several orientations, the simulation is relatively straightforward, as there are static and 
well-defined magnetic parameters corresponding to non-exchanging states, at least on the 
EPR timescale defined by T2 relaxation. Additionally, if the diffusion is much faster than 
T2, then we recover an isotropic case with complete averaging and a single state. The 
simulation becomes more complicated when rotational diffusion on the order of T2 is 
present, due to multiple states and incomplete rotational averaging generating additional 
 
Fig. 24. Fitting of EPR spectra by simulation. Conventional EPR spectra of nitroxide spin labels 
can be simulated and fit by least squares minimization (right). Key parameters of the EPR 
spectrum, including electron g, hyperfine T, rotational diffusion R, order parameter S, and probe 
orientation  (left) can be systematically varied to produce the best fit. Screenshot from 
MultiComponent by Christian Altenbach [89]. 
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states. However, several dedicated EPR simulation programs have been developed by 
Jack Freed, David Schneider, and David Budil [110, 113, 114]. These programs utilize 
Sturm-Lioville theory along with parallelized matrix calculations.to quickly simulate 
these slow, but not immobilized, EPR spectra. As a result, we can simulate conventional 
EPR spectra of nitroxide spin labels in the fast, intermediate, and slow limits. 
 Fitting EPR spectra by simulation can be challenging due to the number of 
variables in the fit. A typical EPR simulation model will contain ~10 parameters unique 
to the sample, including but not limited to electron g tensor, hyperfine T tensor, rotational 
diffusion tensor, and order parameter. Assumptions are often employed to constrain these 
fits, including previous measurements on similar samples (frozen, randomly oriented, 
etc), and physical considerations like axial or isotropic symmetries. Additionally, only a 
few parameters are varied at one time, and correlation matrices produced by the fitting 
software can be consulted to control for overparameterization. Global fitting of several 
related sample spectra (parallel/perpendicular bicelles, X/Q-band, etc) is also a common 
tactic. Several models are often compared, as the concept of a ‘best’ model is somewhat 
elusive. Despite these shortcomings, this is perhaps the most quantitative method of EPR 
data analysis. 
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3.1 Summary 
 We have used electron paramagnetic resonance (EPR) to probe the homo- and 
hetero-oligomeric interactions of reconstituted sarcoplasmic reticulum Ca-ATPase 
(SERCA) and its regulator phospholamban (PLB). SERCA is responsible for restoring 
calcium to the sarcoplasmic reticulum to allow muscle relaxation, while PLB inhibits 
cardiac SERCA unless phosphorylated at Ser16. To determine whether changes in protein 
association play essential roles in regulation, we detected the microsecond rotational 
diffusion of both proteins using saturation transfer EPR (STEPR). Peptide synthesis was 
used to create a fully functional and monomeric PLB mutant with a spin label rigidly 
coupled to the backbone of the transmembrane helix, while SERCA was reacted with a 
Cys-specific spin label. STEPR revealed that sufficiently high lipid/protein ratios 
minimized self-association for both proteins. Under these dilute conditions, labeled PLB 
was substantially immobilized following co-reconstitution with unlabeled SERCA, 
reflecting their association to form the regulatory complex. Ser16 phosphorylation 
slightly increased this immobilization. Complementary measurements with labeled 
SERCA showed no change in mobility following co-reconstitution with unlabeled PLB, 
regardless of its phosphorylation state. We conclude that phosphorylating monomeric 
PLB can relieve SERCA inhibition without changes in the oligomeric states of these 
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3.2 Introduction 
 Muscle relaxation is induced by the active transport of Ca
2+
 from the cytoplasm 
into the sarcoplasmic reticulum (SR). The SR Ca
2+
-ATPase (SERCA) is a 994-residue 
enzyme that transports two Ca
2+
 into the SR lumen per ATP hydrolyzed (Fig. 25, left) 








Fig. 25. Structural models of SERCA (left, crystal structure 1IWO [11]) and monomeric PLB (right, 
hybrid NMR structure 2KB7 [22]). All experiments in this study were conducted with the 
monomeric form of PLB. The amino acid TOAC (bottom right), containing a nitroxide spin label 
rigidly coupled to the -carbon, is incorporated at position 36 (gray star) on PLB; PLB residues 41 
and 46 (gray) are mutated to Phe and Ala. For unlabeled PLB, position 36 is Ala. For spin-labeled 
SERCA, MSL (top right) is attached at Cys 344/Cys 364 (black star) [115]. 
  50 
is allosterically regulated by phospholamban (PLB) [10], a 52-residue membrane protein 
consisting of a 30-residue transmembrane helix and a 16-residue cytosolic helix 
connected by a short, flexible loop [116] (Fig. 25, right). PLB inhibits SERCA by 
decreasing its apparent Ca
2+
 affinity (increasing KCa) [56]. SERCA inhibition is relieved 
physiologically either by micromolar [Ca
2+
] or through PLB phosphorylation at S16 by 
protein kinase A [38], and can also be relieved by PLB point mutations [26, 117, 118]. 
 The regulatory mechanism of the SERCA-PLB complex has considerable 
therapeutic relevance, since inadequate calcium transport has been strongly linked to 
heart failure [119]. Emerging treatments aim to improve cardiac performance by 
increasing SERCA activity through increased SERCA expression [120], allosteric 
activation of SERCA by small molecules [84], or reduced PLB inhibitory potency [80, 
121]. Elucidating this mechanism would provide a roadmap for the rational design of 
PLB mutants and drugs designed to activate SERCA. 
 However, this regulatory mechanism remains controversial. Cross-linking [57] 
and immunoprecipitation [51] studies suggest that dissociation of the SERCA-PLB 
complex is required (Fig. 26, Dissociation Model), while spectroscopic studies suggest 
that PLB remains bound to SERCA following activation by Ser16 phosphorylation [25, 
59, 60], Ca
2+
 addition [122], or PLB loss-of-function mutations [60, 80], indicating that a 
structural rearrangement within the complex can relieve inhibition (Fig. 26, Subunit 
Model). Furthermore, recent studies have identified multiple PLB conformations within 
the regulatory complex that correlate with different inhibitory states [25, 27]. 
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3.2.1 Oligomeric interactions 
 Distinguishing these regulatory mechanisms is made more difficult by the variety 
of protein-protein interactions in this system. While the fundamental inhibitory complex 
is proposed to be a SERCA-PLB heterodimer [10, 30, 123] (Fig. 26, center), both 
proteins form homo-oligomers that can affect SERCA function (Fig. 26). SERCA may 
form functioning dimer and trimer states [124, 125], while larger aggregates lead to 
inhibition [126, 127]. Numerous studies have examined the oligomeric state of SERCA in 
native [128-130] and reconstituted [126] membranes, and several have investigated the 
role of the lipid/protein molar ratio (L/P) in modulating SERCA aggregation [127, 131, 
132], all based on the proportionality between oligomeric size and rotational correlation 
time [133]. In cardiac SR, SERCA inhibition and aggregation are both relieved by 
micromolar Ca
2+
 or PLB phosphorylation [134]. Native PLB equilibrates between 
















Fig. 26. Oligomeric interactions of SERCA and PLB. Both proteins have homo-oligomeric 
interactions (left), and bind to form an inhibited SERCA-PLB complex (center). Phosphorylation of 
PLB relieves inhibition (right), which may occur through dissociation of the complex (Dissociation 
Model), or a structural rearrangement within the complex (Subunit Model). 
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leading to increased SERCA inhibition) or stabilized by phosphorylation (leading to 
decreased SERCA inhibition). Thus inhibition depends, at least in part, on the 
concentration of PLB monomer [30]. To simplify analysis and focus on SERCA-PLB 
interactions, we have used (a) a monomeric PLB mutant (AFA-PLB, referred to below as 
PLB) [24] in which oligomerization is eliminated by replacing Cys residues 36, 41, and 
46 with Ala, Phe, and Ala, respectively, and (b) sufficiently high lipid:protein molar 
ratios (L/P) to minimize self-association of both SERCA and PLB. Thus we are able to 
focus solely on the heterodimeric interactions between these two proteins. 
 In the present study, we have characterized the hetero-oligomerization of PLB and 
SERCA using electron paramagnetic resonance (EPR), while minimizing the homo-
oligomerization of both proteins. Rotational motions detected by EPR can be sensitive to 
oligomeric interactions, since the rotational correlation time (R) of the spin-labeled 
protein is proportional to the protein’s transmembrane volume [133]. However, 
conventional EPR is sensitive only to correlation times in the nanosecond range, which is 
appropriate for rotation of aqueous proteins, but not membrane-embedded proteins, 
where the viscosity (and thus R) is orders of magnitude greater. Even in fluid lipid 
bilayers, R values for most integral membrane proteins are in the microsecond range. 
These slow rotational motions are best measured by saturation transfer EPR (STEPR) 
[135, 136], which requires the use of spin probes that are immobilized on the labeled 
protein. In the present study, PLB rotational motion was detected by incorporating the 
spin label TOAC (2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid) into the 
peptide backbone at position 36 in the transmembrane helix (Fig. 25), while SERCA 
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rotational dynamics was detected after covalent reaction with a maleimide spin label (MSL). 
Both labels have been shown to be rigidly attached to their respective proteins, making them 
sensitive to rigid-body rotational diffusion that directly reflects the size of the oligomeric 
complex [23, 128]. We used STEPR to first find conditions where homo-oligomerization 
was minimized, and then to detect the formation of SERCA-PLB hetero-oligomers so as to 
discriminate between the Dissociation and Subunit models (Fig. 26). 
 
3.3 Methods 
3.3.1 Peptide synthesis 
 C36TOAC, C41F, C46A, PLB (36-TOAC-AFA-PLB) and C36A, C41F, C46A 
PLB (AFA-PLB) were synthesized as described previously [23, 98, 137]. Fmoc-TOAC 
was purchased from Toronto Research Chemicals (North York, Ontario) and Fmoc-
protected amino acids were purchased from EMD Chemicals (Philadelphia, PA). Peptides 
were purified by reverse-phase HPLC on a preparative C8 column (Grace Vydac, 
Hesperia CA) using H2O + 0.1% trifluoroacetic acid and isopropanol as mobile phases. 
Peptides were characterized by mass spectrometry and SDS-PAGE. Protein 
concentrations were quantified using a bicinchoninic acid (BCA) assay (Thermo Fisher 
Scientific, Rockford IL). 
 
3.3.2 SERCA purification and spin labeling 
 SR vesicles were prepared from rabbit fast-twitch muscle [138], then resuspended 
to 25 mg/mL total protein in SR buffer (30 mM MOPS, 0.3 M sucrose, pH 7.0). SERCA 
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was purified by reactive red chromatography [139], omitting reducing agents. For spin 
labeling, SERCA was diluted to 10 mg/mL with SR buffer, to which 300 M MSL was 
added from a 50 mM stock in dimethylformamide. After stirring 1 hr at 25 °C, labeled 
vesicles were diluted tenfold in SR buffer and centrifuged 45 min at 30,000g (4 °C) to 
remove unreacted MSL. The resulting pellet was resuspended in SR buffer and purified 
as above. Protein concentrations were quantified using a BCA assay. 
 
3.3.3 Reconstitution of SERCA and PLB 
 Functional reconstitution of SERCA and PLB was carried out as described 
previously, using 4:1 DOPC/DOPE (mol/mol) to yield unilamellar vesicles that are 
optimal for reproducing physiological SERCA-PLB regulatory function [140, 141]. 
These vesicles have an average diameter of 100 nm [141] and thus rotate too slowly to 
affect our saturation transfer EPR spectra [142, 143]. Final buffer composition of EPR 
samples was 50 mM MOPS, 50 mM KCl, 5 mM MgCl2, 0.5 mM EGTA, 210 M CaCl2, 
pH 7.0, resulting in pCa 6.5 to give optimal regulation of SERCA by PLB [122]. 
Identical buffer conditions were used in functional assays, except that CaCl2 was varied 
in order to vary pCa (-log10[Ca
2+
]). An enzyme-coupled ATPase assay was used to 
measure the Ca-dependence of SERCA activity as described previously [80, 140]. As in 
previous publications from our laboratory, EPR experiments were performed at 4 °C to 
maintain protein stability during lengthy STEPR experiments, while functional 
measurements were performed at 25 °C to enhance SERCA activity and permit 
comparison to published work. PLB inhibitory potency is only weakly dependent on 
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temperature [144]. For phosphorylation, the PLB/lipid/detergent mixture (containing 20 
M PLB, before SERCA addition) was incubated 2 hr at 25 °C with 200 IU/mL bovine 
protein kinase A catalytic subunit (Sigma, St. Louis MO) and 1 mM MgATP. Complete 
PLB phosphorylation (> 92%) was confirmed by quantitative Western blotting [145] 
using 10–20% tris-tricine gels (Bio-Rad, Hercules CA). 
 
3.3.4 EPR spectroscopy and data analysis 
 Before EPR experiments, samples were centrifuged 1 hr at 200,000g (4 °C) and 
the pellets resuspended in minimal buffer. 40 L samples were loaded into 22-gauge 
Teflon tubing (Amazon Supply, Miami Lakes FL) threaded through a glass capillary 
(Wiretrol, Drummond Scientific Company, Broomall PA) flame-sealed at one end. The 
Teflon tubing extended 1 cm from the end of the capillary and was plugged with 
Critoseal (Krackeler Scientific, Albany NY). Spectra were acquired at X-band (9.5 GHz) 
with a Bruker EleXsys E500 spectrometer equipped with the ER 4122 SHQ cavity. 
Temperature was maintained at 4 ± 0.2 °C with a quartz dewar insert and a nitrogen gas 
flow temperature controller. Spectra were acquired after sample deoxygenation under 
nitrogen gas (~1 hr) to eliminate the dependence of spectra on oxygen accessibility [111]. 
Microwave field amplitude H1 (G) was calibrated with a solution of 0.9 mM PADS, 50 
mM K2CO3 [111]. 
 Spectral acquisition parameters were set according to Squier et al. [111]. 
Conventional (V1, first harmonic, in-phase) EPR spectra were acquired with H1 = 0.14 G 
microwave field amplitude, 100 kHz modulation frequency, 2 G modulation amplitude, 
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and 120 G sweep width. V1 spectra used for normalization were acquired as above except 
that H1 was set to 0.032 G. STEPR (V2, second harmonic, out-of-phase) spectra were 
acquired with 50 kHz modulation frequency, 5 G modulation amplitude, and 120 G 
sweep width. After null phase determination by minimizing the signal at non-saturating 
microwave intensity (H1 = 0.032 G), H1 was increased to 0.25 G and the V2 spectrum 
recorded. All EPR spectra were baseline-corrected and then normalized, either to ∫∫V1 
(conventional EPR) or to ∫∫ V1 / H1 for H1 = 0.032 G (STEPR). V1 EPR spectra near the 
slow-motion limit were analyzed by evaluating lineshape features L (the outer half-
width of the low-field line, which increases with spin-spin interaction and rotational 
motion) and 2T|| (the splitting between outer extrema, which decreases with rotational 
motion but not with spin-spin interaction) [109, 146]. 
 For V2 spectra, effective rotational correlation times were calculated from an 
integrated intensity parameter (IST), using a correlation plot created from MSL-
hemoglobin samples in glycerol [111]. IST reports an effective rotational correlation time 
that is minimally sensitive to modulation phase errors and thus provides greater precision 
than provided by lineshape parameters [111]. Data plots were produced with Origin 8.1. 
Error bars are SEM (n = 3-5). When no error bar is visible, this indicates that SEM is 
smaller than the plotted symbol. 
 
3.4 Results 
3.4.1 Functional Assays 
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 To confirm that 36-TOAC-PLB retained regulatory function, we reconstituted it 
with SERCA into 4:1 (mol/mol) DOPC/DOPE (1,2-dioleoyl-sn-glycero-3-phosphocholine, 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) vesicles at 700 lipids/SERCA (mol/mol) 
and measured Ca-dependent ATPase activity using a coupled-enzyme assay [140]. 
Results were fit by the Hill equation (Eq. 25): 
 
Figure 2: pCa Curves (Color)





























Fig. 27. Ca-dependence of ATPase activity. Samples were reconstituted at 700 lipids/SERCA 
and 10 PLB/SERCA (mol/mol). ATP turnover was measured at 25 °C, fit by Eq. 25, and 
normalized to Vmax. SERCA-only controls (circles) were compared to samples containing PLB 
(closed squares), 36-TOAC-PLB (closed diamonds), and their pSer16 counterparts (open 
squares and diamonds). pKCa values obtained from the fits were used to quantify SERCA 
inhibition, and are summarized in Table S1. 
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  Eq. 25 
where V is the ATPase rate, Vmax is the ATPase rate at saturating [Ca
2+
], n is the Hill 
coefficient, and pKCa is the pCa where activity is half-maximal. PLB inhibitory potency, 
defined as the decrease in pKCa, was indistinguishable between our spin-labeled construct 
and unlabeled PLB controls (Fig. 27). At 10 PLB/SERCA, where inhibition is maximal, 
pKCa shifted from 6.48  0.01 to 6.00  0.01 (inhibitory potency = 0.48 ± 0.02). When 
PLB was completely phosphorylated (> 92%), inhibition was partially reversed, 
increasing pKCa to 6.30  0.01 (inhibitory potency = 0.18 ± 0.02) and restoring SERCA 
Ca sensitivity to the same extent as phosphorylating unlabeled PLB (Fig. 27). At 0.5 
PLB/SERCA, matching the conditions of some experiments below, the inhibitory 
potency of 36-TOAC-PLB was 0.28 ± 0.03 (unphosphorylated) and 0.12 ± 0.04 
(phosphorylated). These results, including the partial reversal of inhibition by 
phosphorylation, are similar to those reported previously for other PLB derivatives [23, 
25] and demonstrate that 36-TOAC-PLB regulates SERCA normally. We also used 
functional assays to determine whether reacting SERCA with MSL affected its 
interaction with PLB. While MSL decreased Vmax by ~30% as reported previously [130], 
pKCa regulation by PLB was unaltered, indicating that the label does not perturb 
regulatory interactions between the two proteins. 
 
3.4.2 Monomeric mutant AFA-PLB does not aggregate 
 Our goal was to find conditions in which self-association is minimized for both 
PLB and SERCA. We used conventional and saturation transfer EPR to examine spin- 
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Fig. 28. Dependence of conventional EPR spectra of 36-TOAC-PLB on lipid/protein ratio. (a) 
Spectra of 36-TOAC-PLB reconstituted at 200–1000 L/P (b) Outer splitting (2T||, squares) and 
low-field outer linewidth (ΔL, triangles) as a function of L/P. The vertical scales were set so that a 
change in rotational motion would yield changes in ΔL and 2T|| of similar magnitude (but opposite 
sign) [109, 146]. STEPR spectra are given in Fig. S34. 
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labeled PLB or SERCA reconstituted at several L/P. Conventional EPR of 36-TOAC-
PLB detected only a marginal decrease in outer splitting (2T||, Fig. 28) with increasing 
L/P, indicating little or no change in nanosecond rotational dynamics. However, lipid 
dilution did lead to a substantial decrease in the linewidth (ΔL) (Fig. 28b), which could 
arise from decreased nanosecond rotational mobility [109, 146], but this is inconsistent 
with the lack of increased splitting (Fig. 28b). Thus the linewidth decrease is due to 
decreased dipolar broadening from spin-spin interactions, but the observed broadening is 
precisely that expected for a random two-dimensional arrangement of monomers in the 
membrane [147], and would be much greater if PLB oligomers were present, as 
demonstrated by Fig. S32 and Fig. S33. STEPR spectra support this interpretation (Fig. 
S36). Thus this PLB construct remains predominantly monomeric at all L/P tested here. 
 
3.4.3 SERCA does not aggregate above 600 L/P 
 We conducted similar lipid-dilution experiments with MSL-SERCA. 
Conventional EPR spectra (Fig. S35) have no significant dependence on L/P, confirming 
the previous finding that this spin label binds rigidly to SERCA and undergoes no 
nanosecond rotational dynamics [128]. Thus any changes in STEPR spectra (Fig. 29a) are 
due to changes in microsecond rotational motion of SERCA about an axis perpendicular 
to the membrane [128]. These STEPR spectra show that the effective rotational 
correlation time τR decreases substantially from L/P = 200 to 600, to a limiting value of 
~12 μs for L/P > 600. This τR is consistent with the rotational diffusion of monomeric or 
dimeric SERCA [129] based on the Saffman-Delbrück equation [133], which predicts  
  61 
Oxygen Purged MSL-SERCA Lipid Dilution, STEPR + TauR (Offset)
L/P=1000
L/P=200









Lipids per SERCA (mol/mol)
(a)
 
Fig. 29. STEPR of MSL-SERCA as a function of lipid/protein molar ratio (L/P). (a) Representative 
STEPR (V2) spectra of reconstituted MSL-SERCA. (b) Effective rotational correlation times (τR). 
Conventional EPR (V1) spectra are given in Fig. S35. 
 
  62 
that R is proportional to protein transmembrane volume and lipid viscosity. Assuming a 
membrane height of 4 nm [148] and membrane viscosity of 2 – 5 P [149], the Saffman-
Delbrück model yields correlation times of 2 – 4 μs and 8 – 19 μs for SERCA monomers 
and dimers, respectively. We conclude that SERCA undergoes concentration-dependent 
self-association, but that this dependence is negligible for L/P > 600, suggesting the 
presence of stable SERCA monomers or small oligomers. Therefore, further experiments 
were performed at 700 lipids per SERCA to eliminate the formation of homo-oligomers, 
allowing us to focus on the SERCA-PLB interaction. 
 
3.4.4 Effects of phosphorylation and SERCA binding on rotational 
dynamics of spin-labeled PLB 
 We co-reconstituted 36-TOAC-PLB with SERCA to investigate PLB rotational 
dynamics within the regulatory complex, using 700 lipids/SERCA and 2 SERCA/PLB to 
minimize both homo-oligomers and unbound PLB. Conventional EPR spectra of co-
reconstituted samples (PLB + SERCA, pPLB + SERCA) and their PLB-only controls 
(PLB, pPLB) are all near the rigid limit and are virtually identical (Fig. 30a,c), indicating 
no change in nanosecond dynamics or self-association of PLB upon phosphorylation 
and/or SERCA binding. The V1 EPR spectra in Fig. 30a contain subtle ‘shoulders’ on the 
low- and high-field peaks. These could arise from spin-spin interactions (Fig. 28, Fig. 
S32) or the presence of slow restricted-amplitude rotation [150]. However, the V1 spectra 
are not affected by phosphorylation and/or SERCA addition, so the effects on V2 spectra 
(Fig. 30b) must arise from changes in microsecond rotational dynamics. 
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 In contrast to the invariant conventional (V1) spectra (Fig. 30a,c), STEPR (V2) 
revealed significant changes in microsecond dynamics (Fig. 30b,d). SERCA decreased 
PLB mobility substantially, with τR increasing from 1.9 ± 0.4 μs (PLB) to 5.6 ± 0.2 μs 
(PLB + SERCA), consistent with the large increase in SERCA binding. Ser16 
phosphorylation had no significant effect on PLB dynamics in the absence of SERCA 
(Fig. 30b,d), but increased τR slightly in the presence of SERCA, from 5.6 ± 0.2 s to 6.5 
± 0.1 s (Fig. 30d). This larger τR is probably not due to increased binding to SERCA 
(since that would increase inhibition) or to increased PLB aggregation (since that is 
Oxygen Purged Co -Reconstituted Samples, Conventional and STEPR + Parameters (Colo r) Norm Correlation Time
(d)(c)
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(a) V1 (b) V2'
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Fig. 30. Effects of Ser16 phosphorylation and SERCA on EPR of 36-TOAC-PLB. (a) 
Conventional (V1) EPR spectra and (b) STEPR (V2) spectra of 36-TOAC-PLB as affected by 
phosphorylation (pPLB) and/or SERCA (2 SERCA/PLB). (c) Outer splitting 2T|| measured from 
conventional EPR spectra in (a). (d) Effective rotational correlation times from STEPR spectra in 
(b). Typical normalized spectra are shown in (a) and (b). Bar graphs in (c) and (d) show mean 
values and SEM for n = 3-5 trials. 
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inconsistent with the V1 spectra in Fig. 30a), so it must be due to some structural change 
of the SERCA-PLB complex that alters either the tilt of the PLB TM domain or the 
frictional interaction of the SERCA-PLB complex with lipid [112, 151, 152]. In any case, 
it is clear that PLB does not dissociate from SERCA following phosphorylation, since 
this would cause a substantial decrease in the rotational correlation time, making the blue 
(pPLB) and purple (pPLB + SERCA) spectra identical (Fig. 30c,d). Indeed, a slight 
increase in τR was observed due to phosphorylation (Fig. 30d), and the blue and purple 
spectra are quite different (Fig. 30c), so Fig. 30 clearly contradicts the Dissociation 
Model and strongly supports the Subunit Model (Fig. 26). 
 
3.4.5 Rotational dynamics of spin-labeled SERCA reconstituted with PLB 
 To determine whether the results of Fig. 30 were affected by changes in SERCA 
aggregation, we performed identical experiments except using MSL-SERCA and 
unlabeled PLB. Both V1 (Fig. S36) and V2 (Fig. 31) detect no change in SERCA 
rotational dynamics due to PLB or pPLB. The addition of 0.5 PLB per SERCA should 
increase the transmembrane volume (and thus the rotational correlation time) by only 
~5% [133], within the experimental error of our measurements (~10%, Fig. 30d). This 
indicates that the aggregation state of SERCA is not significantly perturbed by PLB 
binding or phosphorylation under these dilute conditions (700 lipids/SERCA and 2 
SERCA/PLB), despite substantial functional effects. These findings indicate that 
regulatory effects of PLB do not arise solely from modulating SERCA aggregation, 
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although such phosphorylation-dependent aggregation does contribute to functional 
regulation in cardiac SR [134]. 
 Rotational correlation times determined from STEPR spectra are effective, and 
depend on several parameters that are not easily controlled or evaluated, such as probe 
orientation relative to the diffusion axis [153] and spin label environment [111]. In 
addition, it is likely that the TM domain of PLB has residual small-amplitude rotational 
flexibility relative to SERCA. These factors probably contribute to the significant 
differences between the V1 spectra of the SERCA-PLB complex with labeled PLB (Fig. 
30a) or labeled SERCA (Fig. S36), and to the shorter R values determined from V2 
spectra of the complex with labeled PLB (Fig. 30b), compared to labeled SERCA (Fig. 
31). Therefore, our key conclusions come from comparing the V2 spectra of a particular 
spin-labeled protein (36-TOAC-PLB or MSL-SERCA), as perturbed by factors (protein-
MSL-SERCA Co-Reconstituted Samples, STEPR + Parameters (Color)
 SERCA
 SERCA + PLB





































Fig. 31. STEPR (V2) spectra of MSL-SERCA. Experimental conditions are as in Fig. 30, using 
MSL-SERCA and unlabeled PLB. Rotational correlation times did not vary significantly among 
these samples and were consistent with the data in Fig. 29 at 700 lipids/SERCA (13 ± 4 s). 
Conventional EPR spectra also showed no significant changes (Fig. S36). 
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 We have used EPR to investigate the tendencies of SERCA and the monomeric 
AFA-PLB to form homo- and hetero-oligomers in reconstituted membranes. By 
systematically varying the lipid/protein molar ratio (L/P), we found that SERCA self-
association occurs at low L/P but is eliminated for L/P > 600 (Fig. 29), even in the 
presence of 0.5 PLB/SERCA (Fig. 31). We also showed that TOAC-labeled PLB does 
not self-associate under the conditions of this study (Fig. 28). Thus the data in Fig. 30 
reflect directly the rotational dynamics of PLB alone or in complex with SERCA. Since 
phosphorylation and SERCA binding caused no significant effects on PLB nanosecond 
dynamics as detected by conventional EPR (Fig. 30, left), the changes in STEPR (Fig. 30, 
right) are due to microsecond rigid-body dynamics of PLB. Thus SERCA does 
immobilize PLB by binding it, but phosphorylation does not dissociate PLB from 
SERCA, supporting the Subunit Model (Fig. 26, bottom right). 
 
3.5.1 AFA-PLB is monomeric in lipid bilayers at high L/P, even after 
phosphorylation 
 While the null-Cys PLB mutant AAA-PLB, similar to AFA-PLB, was found 
previously to be monomeric by SDS-PAGE [137, 154], solid-state NMR studies 
suggested that AAA-PLB is substantially aggregated in reconstituted membranes at the 
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extremely low L/P value of 20 [155]. 36-TOAC-AFA-PLB shows substantial broadening 
of the V1 spectrum at 20 L/P, consistent with aggregation (Fig. S32), along with dramatic 
effects on the V2 spectrum (Fig. S33), showing that PLB aggregation is detectable if 
present. In contrast, our EPR experiments performed between 200 and 1000 L/P did not 
reveal significant PLB aggregation (Fig. 28). This is the most direct demonstration to 
date that AFA-PLB behaves as a monomer in reconstituted bilayers, whether 
phosphorylated or not. In previous studies, it was shown that the pentameric propensity 
of wild-type PLB increases with phosphorylation [30], and that SERCA preferentially 
binds to the PLB monomer [156]. Thus it remains likely that the decrease in PLB 
monomer concentration due to phosphorylation plays a significant role in relieving 
SERCA inhibition [30, 157]. However, the present results show that some relief of 
inhibition by phosphorylation occurs even under conditions where PLB oligomers do not 
form. 
 
3.5.2 SERCA self-association occurs only at low L/P and is not induced by 
PLB at high L/P 
 The oligomeric state of SERCA for optimal function has been postulated to range 
from monomeric to tetrameric [125, 129, 158-160], while larger aggregates have been 
shown to decrease SERCA activity, whether induced by crosslinking [161], cationic 
peptides [162, 163], cationic local anesthetics [164], mismatch in lipid bilayer thickness 
[165], small-molecule SERCA inhibitors [124, 166], or PLB [134, 167]. Most 
importantly, inhibition relief in cardiac SR by either Ca
2+
 or phosphorylation correlates 
  68 
with decreased SERCA aggregation [134]. The present study does not contradict these 
findings; SERCA aggregation probably plays a significant physiological role in both 
skeletal and cardiac SR. However, our results show that at low protein concentrations in 
the membrane (at high L/P), significant changes in SERCA inhibition by PLB occur 
without significant changes in SERCA aggregation (Fig. 31). 
 
3.5.3 Binding of TOAC-spin-labeled PLB to SERCA is clearly detected by 
STEPR 
 STEPR shows that reconstitution with SERCA decreases the microsecond 
mobility of 36-TOAC-AFA-PLB substantially, consistent with binding (Fig. 30b&d), 
while conventional EPR detects no change in nanosecond motion or PLB aggregation. 
This complex formation is consistent with FRET from SERCA to PLB in a similar 
reconstituted system [27]. 
 
3.5.4 Phosphorylation causes a structural change in the SERCA-PLB 
complex, not dissociation 
 Phosphorylation of SERCA-bound PLB at Ser16 does not increase its rotational 
mobility, and thus does not dissociate it from SERCA under conditions of our study (Fig. 
30). In fact, an increase in the effective rotational correlation time is observed, indicating 
a structural change in the SERCA-PLB complex that decreases mobility or changes the 
tilt of the PLB TM domain. This result supports the Subunit Model (Fig. 26, bottom 
right), though future studies are needed to characterize the structural change. Since the 
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concentrations of SERCA and PLB, as well as the PLB/SERCA ratio, are much higher in 
cardiac SR than in the samples considered here, it is unlikely that phosphorylation of 
PLB causes significant dissociation under physiological conditions. While previous 
studies have found that PLB is in dynamic equilibrium between free and SERCA-bound 
states [35, 80], our data indicates that PLB phosphorylation does not perturb this binding 
equilibrium significantly. 
 The present study used the SERCA1a isoform from skeletal SR. There is no 
known difference between the functional or physical interaction of PLB with SERCA1a 
and SERCA2a [17, 157, 168], but future studies with the SERCA2a isoform will be 
needed to rule this out. Previous studies using spin or fluorescent probes of 
phosphorylated PLB interacting with SERCA are consistent with the conclusions of the 
present study [25, 59, 60]. However, this is the first study of the SERCA-PLB interaction 
using a probe rigidly coupled to the transmembrane domain of PLB, thus reporting 
reliably the rotational mobility of PLB and showing that Ser16 phosphorylation does not 
dissociate the inhibitory transmembrane domain [137] of PLB from SERCA. 
 
3.6 Conclusions 
 We have used STEPR to detect the microsecond rotational mobilities of SERCA 
and AFA-PLB in reconstituted membranes, providing direct insight into their oligomeric 
interactions, as perturbed by phosphorylation. At L/P ≥ 600 and PLB/SERCA = 0.5, 
SERCA does not change its state of self association due to PLB or pPLB, both of which 
are strongly immobilized by SERCA binding. Under these conditions, relief of SERCA 
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inhibition must be due to a structural change within the SERCA-PLB complex, not to 
dissociation of the complex. 
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Table S1. pKCa values from functional experiments shown in Fig. 27. 






















Fig. S32. Conventional EPR spectra of 36-TOAC PLB at 1000 L/P (gray, same conditions as in 
Fig. 28) and 20 L/P (black), showing greatly enhanced spin-spin interactions due to aggregation 
at 20 L/P. 




















Fig. S33. STEPR spectra of 36-TOAC PLB at 1000 L/P (gray, same conditions as in Fig. 28) and 
20 L/P (black). The black spectrum is strongly attenuated by spin-spin interactions [130], which 
are evident in the conventional EPR spectra of Fig. S32. Thus STEPR is quite sensitive to self-
aggregation of this protein, which does not occur above 600 L/P. 
























Fig. S34. STEPR spectra of 36-TOAC-PLB as a function of L/P (see figure legend), 
corresponding to the same samples as in Fig. 28. The increase in spectral intensity with 
increasing L/P (leveling off at high L/P) is consistent with decreasing spin-spin interactions [130], 
as documented in Fig. 28. STEPR lineshapes are essentially invariant above 600 L/P, supporting 
the conclusion that AFA-PLB is monomeric. 

























Fig. S35. Conventional EPR spectra of MSL-SERCA as a function of L/P, corresponding to the 
data shown in Fig. 29. The invariant spectra show that there are no significant changes in 
nanosecond rotational motion or spin-spin interactions due to variation of L/P, so all changes in 
STEPR spectra (Fig. 29) are due to μs rotational diffusion of SERCA. Average 2T|| = 68.2 G. 












 SERCA + PLB
 SERCA + pPLB
 
Fig. S36. Conventional EPR of MSL-SERCA reconstituted with unlabeled PLB, corresponding to 
the data shown in Fig. 31. The invariant spectra show that there are no significant changes in 
nanosecond rotational motion or spin-spin interactions due to PLB binding or phosphorylation, so 
STEPR spectra (Fig. 31) report microsecond rotational diffusion of SERCA. 
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4.1 Summary 
 We have optimized the magnetic alignment of phospholipid bilayered micelles 
(bicelles) for EPR spectroscopy, by varying lipid composition and temperature. Bicelles 
have been extensively used in NMR spectroscopy for several decades, in order to obtain 
aligned samples in a near-native membrane environment and take advantage of the 
intrinsic sensitivity of magnetic resonance to molecular orientation. Recently, bicelles 
have also seen increasing use in EPR, which offers superior sensitivity and orientation 
resolution. However, the low magnetic field strength (less than 1 T) of most conventional 
EPR spectrometers results in homogeneously oriented bicelles only at a temperature well 
above physiological. To optimize bicelle composition for magnetic alignment at reduced 
temperature, we prepared bicelles containing varying ratios of saturated (DMPC) and 
unsaturated (POPC) phospholipids, using EPR spectra of a spin-labeled fatty acid to 
assess alignment as a function of lipid composition and temperature. Spectral analysis 



























Fig. 37. Graphical Summary. Conventional DMPC-only bicelles (top, black) are poorly aligned at 
298 K. Bicelles with a 1:1 molar mixture of POPC and DMPC (bottom, black and red) align 
homogeneously at 298 K. 
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showed that bicelles containing an equimolar mixture of DMPC and POPC 
homogeneously align at 298 K, 20 K lower than conventional DMPC-only bicelles. It is 
now possible to perform EPR studies of membrane protein structure and dynamics in 
bicelles at physiological temperatures and below. 
 
4.2 Introduction 
 For several decades, bicelles have been used in magnetic resonance studies of 
membrane protein structure and dynamics [169]. A bicelle contains a flat patch of lipid 
bilayer comprised of long-chain lipids such as 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (14:0 PC or DMPC), surrounded by a rim of short-chain lipids such as 
1,2-dihexanoyl-sn-glycero-3-phosphocholine (6:0 PC or DHexPC) protecting the 
hydrophobic core of the bilayer. Due to their negative magnetic susceptibility, bicelles 
placed in a sufficiently strong magnetic field will align with the membrane symmetry 
axis (membrane normal) perpendicular to the applied magnetic field [170]. This magnetic 
susceptibility can be altered by addition of paramagnetic lanthanides, which bind to lipid 
headgroups within bicelles, allowing for both parallel and perpendicular alignment [171]. 
In a well-prepared sample containing many bicelles, the alignment homogeneity is 
excellent, providing a more physiological alternative to other anisotropic membrane 
systems such as partially dehydrated lipid bilayers supported on glass plates [172] or 
lipid-containing crystals [173]. Since transmembrane proteins can be uniformly oriented 
in an aligned bicelle sample, techniques with sensitivity to orientation, such as nuclear 
magnetic resonance (NMR) and electron paramagnetic resonance (EPR), can be used to 
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measure probe orientation with high accuracy relative to the applied magnetic field [174-
176], thus providing crucial information about protein structure and dynamics relative to 
the membrane. 
 Magnetically aligned bicelles have been most widely used in NMR, but bicelles 
applications in EPR using nitroxide spin labels have grown in recent years [177]. Due to 
the large magnetic moment of the electron spin, EPR offers much greater sensitivity than 
NMR, making possible much briefer experiments on much smaller samples, at more 
physiological lipid/protein ratios [61]. However, the substantially lower magnetic field 
strength (typically ~ 0.35 T of an X-band EPR spectrometer vs 16 T for 700 MHz NMR 
spectrometer) requires that bicelle composition must be modified to produce adequate 
alignment homogeneity. Protein orientation homogeneity in aligned bicelles is improved 
through addition of cholesterol, which acts to stabilize bicelle rigidity, as well as 
paramagnetic lanthanides [178, 179]. 
 Homogeneous bicelle alignment is significantly influenced by lipid phase 
transitions, which are especially important in the case of the comparatively weak EPR 
magnetic field. At lower temperatures (~270 K), bicelles exist in an isotropic phase that is 
not readily aligned magnetically [180]. At higher temperatures (~290 K), bicelles 
transition into a nematic crystal phase, where they may be partially aligned, but are 
characterized by flexible lipid interactions that result in overall disorder [180]. At still 
higher temperatures (ca 320 K), bicelles transition into a smectic crystal phase, with rigid 
lipid interactions [181]. Bicelles in this smectic crystal phase can be identified by a 
substantial increase in sample viscosity and opacity, compared with the nematic and 
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isotropic phases [182]. The typical procedure for magnetic alignment of bicelles for EPR 
involves increasing temperature to drive the bicelle mixture from the isotropic phase to 
the smectic phase in the presence of a strong magnetic field (~ 1 T, the maximum field 
available on X-band EPR spectrometers). It has been shown that this alignment remains 
stable for hours after decreasing the field to 0.35 T for X-band EPR measurements [181]. 
The need for high temperatures to achieve the smectic phase presents a problem for 
studies of many proteins, as increased dynamics and thermal degradation complicate 
orientation measurements [183]. A possible solution is suggested by NMR studies in 
which the unsaturated phospholipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(16:0-18:1 PC or POPC) has been shown to improve bicelle alignment at lower 
temperatures [172, 184]. 
 
4.3 Methods 
 In the present study, we optimize bicelle lipid composition with DMPC and 
POPC, in order to determine the minimum temperature for homogeneous alignment in X-
band EPR experiments. Bicelles were prepared based on methods previously described 
[104]. Briefly, 5-DOXYL-stearic acid (5-DSA, Sigma Aldrich, St. Louis, MO) was 
combined with lipids (DMPC, POPC, DHexPC, Avanti Polar Lipids, Alabaster, AL), and 
cholesterol (Sigma Aldrich), all dissolved in chloroform. This produced bicelles with 700 
long-chain lipids per 5-DSA [61], 13% cholesterol (mol cholesterol / mol long-chain 
lipid) [104, 178], and q (molar ratio of long- to short-chain lipids) = 4 [172]. Organic 
solvent was evaporated under N2 gas and then completely removed by storage in a 
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vacuum desiccator overnight. 100 mM HEPES buffer (pH 7.0) was added up to 25% 
(lipid mass / buffer volume), then the sample was vortexed for 2 min and placed on ice 
for 5 min. After repeating this process twice, samples were sonicated in an ice bath for 30 
min [104]. Prepared lanthanide stock (TmCl3*6H20 (Sigma Aldrich, St. Louis, MO) in 
100 mM HEPES) was added to the sample up to 20% (mol lanthanide / mol long-chain 
lipid), then vortexed for 2 min [104]. Samples were then flash-frozen in liquid N2 three 
times to further homogenize, yielding a clear, viscous fluid. 16 L of the sample was 
pipetted into a 0.6/0.84 mm ID/OD glass capillary (Vitrocom, Mountain Lakes, NJ), in 
order to span the active portion of the EPR resonator. The capillary was then plugged 
with Critoseal (Krackeler Scientiﬁc, Albany, NY). Randomly oriented samples (vesicles) 
were prepared identically to bicelles, with the omission of the short-chain lipid DHexPC. 
 EPR experiments were performed on a Bruker EleXsys E500 spectrometer 
equipped with an ER 4122 SHQ spherical resonator. Sample temperature was maintained 
at ± 0.2 K using a quartz dewar attached to a nitrogen gas temperature controller. 
Samples were first placed in the resonator and equilibrated at 273 K for 5 min. To align 
bicelles, the field strength was raised to 1.1 T [181], then the temperature was raised 2 K 
per minute up to the final (alignment) temperature, at which point the sample was 
incubated for 20 min at 1.1 T field strength. The EPR spectrum was then acquired at X-
band field strength (~3400 G) at the desired alignment temperature. For randomly 
oriented vesicle samples, spectra were acquired immediately after the initial 5 minute 
equilibration at the desired temperature. Spectra were acquired with the following 
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parameters: 2 mW microwave power, 1 G peak-to-peak modulation amplitude, 120 G 
sweep width, and 20.48 ms time constant and conversion time. 
 EPR spectra were background-corrected and normalized to the double integral 
[185]. Least-squares minimization fitting was performed in MultiComponent, an EPR 
simulation program that is optimized for fitting spectra to models involving multiple 
populations (Altenbach et al) [186]. Data was fit based on a model of microscopic order, 
macroscopic disorder (MOMD). Starting values for the DOXYL g-factor and hyperfine 
tensors were obtained from a previous study [187], and further refined with the spectrum 
of a 5-DSA vesicle sample acquired at 200 K (see Supplemental Information for fitting 
details). The model for vesicle samples assumed a single, randomly oriented component 
with isotropic rotational diffusion and Lorentzian linewidth tensors, as well as an 
orienting potential determined by c20. Oriented bicelle spectra were fit to a two-
component model: randomly oriented and aligned. The randomly oriented component 
was assumed to be the same as that of the corresponding vesicle sample. For the aligned 
component, all parameters were fixed to those of the random component, with the 
exceptions that NORT (the number of orientations calculated) was reduced from 20 to 1, 
and the orienting potential coefficients c20, c22, and c40 were allowed to vary. Rigorous 
fitting revealed that constraining the dynamics (R) and magnetic parameters (g, A) for 
the aligned component to those from the randomly oriented component requires 
additional orienting coefficients, presumably to account for subtle orientation disorder in 
the aligned component. Alignment homogeneity was characterized by the mole fraction 
of the aligned component relative to the randomly oriented component (“fraction 
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aligned” below). Aligned bicelle spectra were also fit to a single aligned component, 
allowing disorder in the orienting potential, but these fits gave much higher χ2 values than 
the two-component model described above. Standard error of the mean (SEM) for fit 
parameters was determined by least-squares minimization fitting in NLSL (Freed et al) 




 We began by verifying the bicelle alignment methodology of Ghimire and co-
workers [104], preparing conventional DMPC bicelles containing 5-DSA, and using 
thulium to align bicelles parallel to the magnetic field up to 318 K and 298 K. Fig. 38 
shows the EPR spectra of 5-DSA in randomly oriented vesicles (top) and parallel aligned 


















Fig. 38. EPR spectra of 5-DSA in conventional DMPC vesicles (top) and bicelles with membrane 
normal oriented parallel to the instrument magnetic field (bottom) aligned at 318 K (left) and 298 
K (right). 
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bicelles (bottom). There is a substantial change in lineshape upon alignment of bicelles at 
318 K, reflecting a uniform orientation distribution of the 5-DSA spin label. These 
spectra are consistent with previous studies of 5-DSA in conventional DMPC bicelles 
[189]. When this experiment was repeated using an alignment temperature of 298 K (Fig. 
38, right), there was no significant spectral change between the vesicle and bicelle 
samples, suggesting that conventional DMPC bicelles cannot be uniformly aligned at 298 
K. 
 Next, we optimized the POPC:DMPC molar ratio for bicelles by performing a 
titration experiment with different POPC:DMPC ratios. During this experiment, we 
aligned bicelle samples up to 298 K, consistent with previous NMR experiments using 
bicelles of similar composition [172, 184, 190]. Fig. 39 shows the EPR spectra of 5-DSA 
in vesicles and aligned bicelles at 298 K as a function of POPC:DMPC molar ratio. Both 
the control (0 POPC:DMPC) and 1:4 POPC:DMPC bicelle samples were poorly aligned. 
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                          POPC/DMPC                           POPC/DMPC




Fig. 39. EPR spectra of 5-DSA in POPC/DMPC vesicles (left) and bicelles (right) as a function of 
POPC:DMPC molar ratio (left text). All spectra were acquired at 298 K. The relative amount of 5-
DSA in uniformly oriented bicelles is indicated as fraction aligned (right text). 
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These samples possess similar vesicle and aligned bicelle spectra, as well as low 
alignment fractions. Upon increasing the POPC:DMPC molar ratio to 1:2, there was a 
substantial change in the aligned bicelle EPR lineshape, indicative of improved alignment 
homogeneity. The aligned component now accounts for a majority of the spectrum 
(fraction aligned = 0.94), although there is some residual randomly oriented component. 
At 1:1 POPC:DMPC, the aligned bicelle EPR sample was homogeneously aligned, with a 
fraction aligned greater than 0.99. This spectrum is well-fit with only the aligned 
component. For higher POPC:DMPC molar ratios, the fraction aligned is slightly 
degraded, possibly due to a perturbation in bilayer structure from high POPC 
concentration. The data in Fig. 39 therefore suggests that a 1:1 molar ratio of 
POPC:DMPC is the optimum value for aligned bicelle EPR. This is consistent with NMR 
experiments that have used 1:1 POPC:DMPC and observe homogeneous alignment at 
ambient temperature [184]. 
 Next, we characterized the alignment homogeneity of conventional DMPC 
bicelles as a function of alignment temperature. Fig. 40 shows the EPR spectra of 5-DSA 
in vesicles and aligned conventional DMPC bicelles, using alignment temperatures 
between 278 K and 318 K. Aside from small changes in splitting and linewidth due to 
temperature, the aligned bicelle spectra from 278 K to 298 K are nearly identical. The 
bicelle samples corresponding to these three spectra were poorly aligned, with alignment 
fractions below 0.1. At 308 K, the aligned bicelle spectrum changes slightly, particularly 
in the region immediately flanking the central resonance, and the fraction aligned 
increases to 0.29. In contrast, the 318 K spectrum possesses a strikingly different 
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lineshape, and is well-fit by only the aligned component. Therefore, a temperature of 318 
K is required for homogeneous alignment of conventional DMPC bicelles. This result is 
consistent with previous EPR experiments using this conventional bicelle method that 
observe complete alignment at 318 K [178, 179, 181]. 
 Fig. 41 shows the EPR spectra of 5-DSA in vesicles and aligned bicelles with 1:1 
POPC:DMPC, using alignment temperatures between 278 K and 318 K. Although the 
278 K spectra indicate poor alignment, substantial alignment is observed beginning at 
288 K (fraction aligned = 0.80). At 298 K, the fraction aligned is greater that 0.99, 
indicative of homogeneous alignment. At 308 K and 318 K, the fraction aligned 
decreases slightly. This suggests that high temperature destabilizes POPC/DMPC bicelle 
alignment, possibly either through thermal motion or transition to another isotropic 
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Fig. 40. EPR spectra for 5-DSA in DMPC-
only vesicles (left) and bicelles (right) as a 
function of alignment temperature (left text). 
The relative amount of 5-DSA in uniformly 
oriented bicelles is indicated as fraction 
aligned (right text). 
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Fig. 41. EPR spectra for 5-DSA in 1:1 
POPC:DMPC vesicles (left) and bicelles 
(right) as a function of alignment 
temperature (left text). The relative amount 
of 5-DSA in uniformly oriented bicelles is 
indicated as fraction aligned (right text). 
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bicelle phase. Importantly, the alignment homogeneity of these POPC/DMPC bicelles at 
298 K is comparable to that of conventional DMPC-only bicelles at 318 K, as both 
spectra are well-fit by a single oriented spectral component (fraction aligned ~ 1). 
 
4.5 Conclusions 
 In summary, through optimization of lipid composition and alignment 
temperature, we found that bicelles containing a 1:1 mixture of POPC and DMPC 
homogeneously align at 298 K, which is 20 K less than the alignment temperature 
required for conventional DMPC-only bicelles. This decrease in alignment temperature is 
likely due to POPC reducing bicelle phase transition temperatures (TM), since TM for pure 
POPC is 26 K lower than that for pure DMPC. The vesicle EPR spectra for both DMPC-
only and POPC/DMPC samples report similar dynamics and magnetic parameters (see 
Supplemental Information), suggesting that the lipid environments are also similar. The 
POPC/DMPC bicelles described in this work should be excellent reconstitution systems 
for orientation studies of proteins with structural dynamics that are sensitive to 
temperature, such as the regulatory proteins sarcolipin and phospholamban, as well as the 
SR Ca-ATPase SERCA. 
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Fig. S42. EPR spectrum and best fit for 5-DSA in randomly oriented conventional DMPC bicelles 












Vesicle 0 200 2.0083 2.0059 2.0030 34.07 5.54
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Table S2. Fitting parameters for 5-DSA bicelle sample from Fig. 38. 
























Vesicle 0 298 2.0083 2.0059 2.0030 31.71 6.22 7.72 3.57 0 0
Bicelle 0 298 2.0083 2.0059 2.0030 31.71 6.22 7.72 7.20 -8.78 -0.24
Vesicle 1:4 298 2.0083 2.0059 2.0030 31.71 6.26 9.23 3.57 0 0
Bicelle 1:4 298 2.0083 2.0059 2.0030 31.71 6.26 9.23 5.77 -5.76 0.98
Vesicle 1:2 298 2.0083 2.0059 2.0030 31.76 6.24 8.95 3.43 0 0
Bicelle 1:2 298 2.0083 2.0059 2.0030 31.76 6.24 8.95 1.72 -0.86 -0.35
Vesicle 1:1 298 2.0083 2.0059 2.0030 31.58 6.26 10.46 3.77 0 0
Bicelle 1:1 298 2.0083 2.0059 2.0030 31.58 6.26 10.46 1.65 -0.37 -0.58
Vesicle 2:1 298 2.0083 2.0059 2.0030 31.40 6.33 12.43 4.22 0 0
Bicelle 2:1 298 2.0083 2.0059 2.0030 31.40 6.33 12.43 1.60 0.18 -0.74
Vesicle 4:1 298 2.0083 2.0059 2.0030 31.54 6.24 12.24 4.17 0 0
Bicelle 4:1 298 2.0083 2.0059 2.0030 31.54 6.24 12.24 1.67 0.23 -0.91
POPC/DMPC Titration
 
Table S3. Fitting parameters for 5-DSA in POPC/DMPC vesicles and bicelles as a function of 




















Vesicle 0 278 2.0083 2.0059 2.0030 32.89 5.89 371.47 18.69 0 0
Bicelle 0 278 2.0083 2.0059 2.0030 32.89 5.89 371.47 9.41 -1.23 8.63
Vesicle 0 288 2.0083 2.0059 2.0030 32.48 5.70 188.29 16.12 0 0
Bicelle 0 288 2.0083 2.0059 2.0030 32.48 5.70 188.29 9.92 5.16 -2.86
Vesicle 0 298 2.0083 2.0059 2.0030 31.61 6.05 57.04 12.12 0 0
Bicelle 0 298 2.0083 2.0059 2.0030 31.61 6.05 57.04 4.22 -4.53 -0.24
Vesicle 0 308 2.0083 2.0059 2.0030 31.02 6.71 11.39 4.05 0 0
Bicelle 0 308 2.0083 2.0059 2.0030 31.02 6.71 11.39 3.61 4.21 -0.84
Vesicle 0 318 2.0083 2.0059 2.0030 30.72 7.05 7.62 2.94 0 0
Bicelle 0 318 2.0083 2.0059 2.0030 30.72 7.05 7.62 1.80 -0.54 -0.91
DMPC Temperature
 
Table S4. Fitting parameters for 5-DSA in DMPC-only vesicles and bicelles as a function of 




















Vesicle 1:1 278 2.0083 2.0059 2.0030 32.25 5.76 92.71 14.75 0 0
Bicelle 1:1 278 2.0083 2.0059 2.0030 32.25 5.76 92.71 9.86 3.79 -4.14
Vesicle 1:1 288 2.0083 2.0059 2.0030 31.66 6.28 25.26 8.43 0 0
Bicelle 1:1 288 2.0083 2.0059 2.0030 31.66 6.28 25.26 5.87 5.60 -1.10
Vesicle 1:1 298 2.0083 2.0059 2.0030 31.54 6.35 11.44 3.95 0 0
Bicelle 1:1 298 2.0083 2.0059 2.0030 31.54 6.35 11.44 1.62 -0.17 -0.65
Vesicle 1:1 308 2.0083 2.0059 2.0030 31.58 6.54 7.28 2.81 0 0
Bicelle 1:1 308 2.0083 2.0059 2.0030 31.58 6.54 7.28 1.61 -0.21 -0.86
Vesicle 1:1 318 2.0083 2.0059 2.0030 31.40 6.76 5.79 2.25 0 0
Bicelle 1:1 318 2.0083 2.0059 2.0030 31.40 6.76 5.79 1.63 -0.39 -0.94
POPC/DMPC Temperature
 
Table S5. Fitting parameters for 5-DSA in 1:1 POPC:DMPC vesicles and bicelles as a function of 
alignment temperature (see Fig. 41). 
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Fig. S43. EPR spectra and best fit for 5-DSA in POPC/DMPC vesicles (left) and bicelles (right) as 
a function of POPC:DMPC molar ratio aligned and acquired at 298K (see Fig. 39 of the 
manuscript). Acquired EPR spectra are shown in black, and best fits are shown in red. 
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Fig. S44. EPR spectra and best fit for 5-DSA in DMPC-only vesicles (left) and bicelles (right) as a 
function of alignment temperature (see Fig. 40 of the manuscript). Acquired EPR spectra are 
shown in black, and best fits are shown in red. 
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Fig. S45. EPR spectra and best fit for 5-DSA in 1:1 POPC:DMPC vesicles (left) and bicelles 
(right) as a function of alignment temperature (see Fig. 41 of the manuscript). Acquired EPR 
spectra are shown in black, and best fits are shown in red. 
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5.1 Summary 
 We have applied a bifunctional spin label and EPR spectroscopy to the study of 
membrane protein structural topology in magnetically-aligned bicelles, using monomeric 
phospholamban (PLB) as a model system. Bicelles are a powerful tool for studying 
membrane proteins by NMR and EPR spectroscopies, where magnetic alignment yields 
topological constraints by resolving the anisotropic spectral properties of nuclei and spin 
labels. However, EPR bicelle studies are often hindered by the rotational mobility of 
conventional Cys-linked spin labels, which obscures their orientation relative to the host 
protein. The rigid TOAC label provides high orientation sensitivity but must be 
introduced via solid-phase peptide synthesis, precluding its use in large proteins. Here we 
show that a bifunctional methanethiosulfonate spin label, attached to i and i + 4 Cys 
residues along PLB’s transmembrane helix, offers orientation resolution similar to 
TOAC, while being applicable to large proteins for which synthesis is impractical. 
 
5.2 Introduction 
 Magnetically-aligned bicelles are a powerful tool for studying the structural 
topology of integral membrane proteins by magnetic resonance spectroscopies. 
Reconstitution into aligned bicelles can resolve the anisotropic spectral properties of 
nuclei for NMR or nitroxide spin labels for EPR, yielding valuable information regarding 
protein orientation with respect to the bilayer. Bicelles (bilayered micelles) are mixtures 
of long- and short-chain phospholipids that combine to form patches of long-chain lipid 
bilayers encircled by short-chain lipids. Bicelles possess negative magnetic susceptibility 
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(Δχ), and in the presence of high magnetic fields (B0 ≥ 6 T) will align spontaneously with 
their membrane normal (n) perpendicular to the field (n ⊥ B0). Alignment may be 
enhanced by the addition of lanthanides that associate with bicelle surface and further 
decrease Δχ (Dy3+), or impart a positive Δχ (Tm3+) that ‘flips’ the bicelles such that they 
align with n parallel to the field (n ∥ B0).  
 In solid-state NMR spectroscopy, particularly the 1H/15N PISEMA and SAMMY 
experiments, membrane protein alignment in bicelles (or mechanically-oriented bilayers) 
resolves the 15N – 1H dipolar coupling and 15N chemical shift anisotropies to permit the 
Fig. 1: Bifu ti nal Spin Label
 
Fig. 46. Left: structural formula of BSL. Right: energy-minimized structure of BSL attached at 
positions 32 and 36 on the structure of monomeric PLB. BSL dihedral angles were determined 
from a study by Fleissner and co-workers [93]. 
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determination of transmembrane helical tilt and azimuthal rotation [191]. Similarly, 
sample alignment in conventional EPR can resolve the g-factor and hyperfine coupling 
anisotropies of nitroxides introduced via site-directed spin labeling [192], provided these 
parameters do not undergo significant motional averaging. However, conventional Cys-
linked spin labels often possess residual ps – ns rotational mobility that limits their utility 
in oriented EPR measurements. To overcome this obstacle, the Lorigan Lab has 
pioneered the use of TOAC in bicelle EPR, which suppresses backbone-independent 
probe motion by incorporating the nitroxide group and -carbon into the same six-
membered ring [193]. While the rigidity of TOAC affords high orientation resolution, it 
must be introduced during solid-phase peptide synthesis, precluding its use in large 
proteins. Techniques to introduce TOAC via amber codon suppression have thus far 
proved unsuccessful [194], so bicelle EPR measurements to date have focused 
exclusively on small (< 60 residues) proteins amenable to peptide synthesis [104, 176]. 
 The bifunctional spin label HO-1944 (Fig. 46, hereafter called BSL) is a 
derivative of the popular methanethiosulfonate spin label (MTSL), and reacts with CxxC 
or CxxxC motifs along -helices, or CxC motifs along -sheets. Bifunctional attachment 
significantly restricts probe mobility and orientation with respect to the peptide backbone, 
permitting a variety of EPR measurements that are impractical with monofunctionally-
attached labels. Studies using BSL have probed the µs – ms rotational dynamics of actin-
bound myosin S1 [195, 196] and tropomyosin [90], as well as the orientation of myosin 
S1 in mechanically-oriented muscle fibers [197]. Recently, BSL was shown to enhance 
the resolution of double electron-electron resonance (DEER) distance measurements for 
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both aqueous [93] and membrane [198, 199] proteins, presumably by constraining the 
static disorder of the label. In the present study, we demonstrate that BSL can be used in 
conjunction with magnetically-aligned bicelles to probe the structural topology of 
membrane proteins, with orientation resolution comparable to TOAC. For our model 
system we chose phospholamban (PLB), a single-pass membrane protein that regulates 
the cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA) [200]. Wild-type PLB 
equilibrates between monomeric and homopentameric states, so the purely monomeric 
mutant C36A/C41F/C46A (AFA) was employed to simplify the system and eliminate 
potential spin-spin interactions [201]. The structural topology of AFA-PLB in 
mechanically-oriented bilayers has been thoroughly characterized by hybrid 
solution/solid-state NMR techniques, allowing for the interpretation of our results in the 
context of a high-resolution structure [201]. 
 
5.3 Methods 
 Double-Cys (F32C/A36C) and single-Cys (F32C) PLB constructs were prepared 
by QuikChange mutagenesis of a plasmid encoding the Cys-free monomeric mutant 
C36A/C41F/C46A (AFA) PLB as a cleavable fusion to maltose binding protein (MBP) 
[202]. Expression was carried out in BL21(DE3) cells (Lucigen) grown in Terrific Broth 
at 37 °C and induced with 0.5 mM IPTG once OD600 reached 2.5 – 3.0. Following 
induction, cells were incubated 20 hr at room-temperature before collection by 
centrifugation, after which expressed MBP-PLB was purified by amylose resin 
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chromatography, cleaved with recombinant TEV protease [203], and purified by HPLC 
[204, 205]. 
 Purified, lyophilized PLB was solubilized at 100 M in 50 mM Tris-HCl, 5% 
(w/v) SDS, pH 7.5 and immediately combined with 5-fold molar excess BSL (Toronto 
Research Chemicals) from a 25 mM stock in N,N-dimethylformamide, followed by 16 hr 
incubation at room-temperature with protection from light. The next day, spin-labeled 
protein was re-purified by HPLC and lyophilized as above, then solubilized at ~1 mg/mL 
in trifluoroethanol and stored at -20 °C. Labeling efficiency (> 95%) was determined by 
dissolving a portion of each lyophilized powder in 5% (w/v) SDS and comparing the 
double-integrals of their EPR spectra to that of a 100 M TEMPOL standard, followed by 
determination of protein concentration using a BCA (Thermo Fisher Scientific, Rockford 
IL). Labeling specificity was determined using electrospray ionization mass spectrometry 
(ESI-MS). Briefly, lyophilized powders were solubilized in 50:50 H2O/acetonitrile (v/v) 
containing 0.1% (v/v) mass-spectrometry-grade formic acid (Sigma). Samples were 
characterized by direct infusion onto an Agilent MSD SL Ion Trap operating in positive 
ion mode. 
 Spin-labeled PLB was reconstituted at 1400 long-chain lipids per PLB into 2:2:1 
(mol/mol) DMPC/POPC/DHexPC bicelles containing 13% (mol/mol) cholesterol and 
20% (mol/mol) TmCl3 or DyCl3 [184, 193]. To prepare bicelles, lipid and cholesterol 
stocks in chloroform (Avanti Lipids) were combined with PLB, dried under N2 gas, and 
stored overnight in a vacuum desiccator. The resulting films were resuspended at 25% 
(w/v) in 100 mM HEPES, pH 7.0 by thorough vortexing and ice-water-bath sonication, 
  99 
after which the samples were combined with lanthanides also dissolved in 100 mM 
HEPES. To create lipid vesicles, samples were prepared as described above while 
omitting DHexPC. 
 EPR experiments were performed on a Bruker EleXsys E500 spectrometer 
equipped with an ER 4122 SHQ resonator containing a quartz dewar insert attached to a 
nitrogen gas temperature controller. 16 µL samples were loaded into 0.6 mm inner 
diameter glass capillaries (Vitrocom) and plugged with Critoseal (Krackeler Scientific, 
Albany, NY). For alignment, bicelle samples were first incubated in the resonator for 5 
min at 273 K in the absence of a magnetic field. Next, the field strength was raised to 1.1 
T and the temperature gradually increased to 298 K at a rate of 2 K per minute. Finally, 
the samples were incubated for 20 min at 298 K and 1.1 T before the field strength was 
decreased for EPR measurements. For vesicle samples, spectra were acquired directly at 
298 K or 200 K. Spectra at 298 K were acquired using 1 G peak-to-peak amplitude 
modulation, 5 mW microwave power, and a 120 G sweep width, while spectra at 200 K 
were acquired with 0.1 mW microwave power and a 200 G sweep width. 
 EPR spectra were background-corrected and normalized in WACY, an in-house 
program developed by Edmund Howard [185]. WACY was also used to fit the rigid-limit 
spectra acquired at 200 K. All other spectra were fit using NLSL [113] and the LabView 
program MultiComponent developed by Christian Altenbach. Randomly-oriented spectra 
were fit assuming the microscopic-order macroscopic-disorder (MOMD) model. Initial 
values for the hyperfine and g tensors were taken from the fits to the frozen (200 K) EPR 
spectrum of the lipid vesicle sample. Aligned bicelle spectra were fit globally, again using 
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an isotropic rotational diffusion tensor and the first coefficient of the orienting potential 
(c20). To optimize the fit, values for the axially symmetric hyperfine tensor were allowed 
to vary. During global fitting, the director tilt angles were fixed at 0° (parallel) and 90° 
(perpendicular) while the diffusion tilt angles D and D were allowed to vary. 
 
5.4 Results 
  Prior to our EPR measurements, we performed electrospray ionization (ESI) 
mass spectrometry on both BSL-F32C/A36C-PLB (hereafter called 32/36-BSL-PLB) and 
BSL-F32C-PLB (hereafter called 32-BSL-PLB) to characterize the nature of labeling. 
Our results indicate that the 32/36-PLB construct containing a single, bifunctionally-
attached label is the predominant species (Fig. S50a). This is further supported by the 
absence of dipolar broadening in our EPR spectra, which would be observed if two labels 
were each monofunctionally attached to 32/36-BSL-PLB. In comparison, ESI-MS of 32-
BSL-PLB revealed the predominant species to be monofunctionally-attached BSL with 
an intact, second methanethiosulfonate group (Fig. S50b). Our results are in good 
agreement with those reported previously [93], where monofunctional and bifunctional 
attachment yield similar degrees of BSL immobilization. Notably, the sharp spectral 
features of the 32/36-BSL-PLB spectrum indicate that bifunctional attachment 
predominates in the F32C/A36C sample. 
 To determine the rotational dynamics of BSL-F32C/A36C-PLB in the absence of 
alignment, but still mimicking the bicelle environment, we acquired its spectrum at 298 K 
following reconstitution into DMPC/POPC vesicles containing 13% (mol/mol) 
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cholesterol and 20% (mol/mol) TmCl3. Fig. 47a shows the vesicle spectrum at 298 K, 
revealing a lineshape typical for strongly immobilized, membrane-embedded nitroxides 
(2A∥ = 62.2 G) [106]. In comparison, the EPR spectrum of our labeled single-Cys 
construct in lipid vesicles reports a similar outer splitting (2A∥ = 61.7 G, Fig. S51) but a 
significantly broader linewidth, indicating that the unreacted methanethiosulfonate group 
restricts BSL rotational mobility. This effect has been observed for other mutants, and 
matches the effects of 4-substituted MTSL derivatives [206]. 
 A spectrum of the BSL-32/36-PLB acquired at 200 K (Fig. 47b) reports an outer 
splitting of 66.0 G, indicating that residual ns mobility is present, arising either from BSL 
internal dynamics or the motion of PLB itself. To quantify rotational dynamics, we first 
fit the 200 K spectrum assuming a rigid-limit model, in order to determine values for the 
g-factor and hyperfine tensors (Table 6). These served as initial values when analyzing 
the 298 K spectrum, which was fit assuming the MOMD model [113]. A satisfactory fit 
was obtained using an isotropic rotational correlation time (R) and the first coefficient of 
the ordering potential (c20), corresponding to slow, modestly restricted rotational 
dynamics (R ~ 76 ns, S = 0.36). Similarly, variation of the diffusion tilt angles D and D 
not did significantly improve the fit, likely because the rotational motion is too near the 
rigid limit to detect averaging of the g-factor and hyperfine tensor components. The 
observed correlation time is comparable to the rate of PLB uniaxial diffusion (R = 105 ns 
at 277 K) measured using the TOAC spin label [106], suggesting that BSL is reporting 
the uniaxial diffusion of PLB within the membrane. 
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 To prepare aligned samples, we reconstituted 32/36-BSL-PLB into 2:2:1 
(mol/mol) POPC/DMPC/DHexPC bicelles containing 13% (mol/mol) cholesterol and 
20% (mol/mol) TmCl3 or DyCl3. This lipid composition (omitting lanthanides) was 
demonstrated previously to undergo magnetic alignment between 291 - 298 K at NMR 
field strengths [184], and with the addition of lanthanides we observed complete 
alignment of POPC/DMPC/DHexPC bicelles containing 5-DOXYL-stearic acid as a 
reporter (Fig. S53). Parallel- and perpendicular-aligned bicelle spectra are given in Fig. 
48, and show dramatic differences in outer splitting indicative of alignment. Based on the  
Fig. S2: Comparison of BSL-PLB and MBSL-PLB in Aligned Bicelles




 Magnetic Field (G)
298K
 
Fig. 47. EPR spectra (black) of 32/36-BSL-PLB in randomly-oriented lipid vesicles, and best fits 
(red). (a) 298 K, fit generated by NLSL. (b) 200 K, fit generated by WACY. Parameter values from 
fits are included in Table 6. 
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crystal structure of BSL-T4 lysozyme [93], BSL is predicted to attach along PLB’s 
transmembrane helix with its principal axis (zM) tilted ~70° relative to the helix long axis 
(h, see Fig. 46). For 32/36-BSL-PLB in parallel (n ∥ B0) bicelles, where h is roughly 
collinear with the membrane normal (n), the EPR spectrum should be dominated by xM-
yM contributions and possess a narrow outer splitting. In contrast, perpendicular (n ⊥ B0) 
bicelles should yield a spectrum with substantially wider splitting due to contributions 
from zM. As expected, narrow splitting of the parallel spectrum (Fig. 48a, A∥ = 10.0 G) 
and wide splitting of the perpendicular spectrum (Fig. 48b, A⊥ = 30.6 G) indicate that zM 
is nearly orthogonal to the membrane normal. 





 Magnetic Field (G)
 
Fig. 48. EPR spectra of 32/36-BSL-PLB in bicelles aligned parallel (a) and perpendicular (b) with 
respect to the instrument magnetic field. Black: data. Red: best-fit results of global analysis (Table 
6). 
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 To determine the diffusion tilt angles (D, D) relating the nitroxide principal axis 
(zM) to the director axis (zD), we performed global fitting of the parallel and 
perpendicular bicelle spectra using NLSL, with results given in Table 6. Initial values for 
the g-factor and hyperfine tensors were again taken from the frozen vesicle spectrum, 
though minor variation of both tensors was necessary to optimize the fit. The director tilt 
(Ψ) was fixed at 0° and 90° for the parallel and perpendicular spectra, respectively. As 
with the vesicle spectrum, bicelle spectra were well-described by an isotropic rotational 
diffusion tensor and the first coefficient of the ordering potential, corresponding to slow, 
moderately restricted rotational dynamics (R ~ 61 ns, S = 0.56). For the diffusion tilt 
angles, we found that varying D (90.0°) significantly improved the fit. Variation of D 
(36.8°) also improved the fit quality, however it was only well-defined by global fitting. 
When D ~ 90°, variation of D only interconverts xM and yM, which are not well-resolved 
at X-band, and so the error associated with D is significant. 
 As a control, we also acquired spectra from 32-BSL-PLB reconstituted in parallel- 
and perpendicular-aligned bicelles, shown in Fig. S52. The parallel-aligned spectrum 
clearly contains multiple components, while the outer splitting appears to decrease, 
suggesting that 32-BSL-PLB preferentially adopts conformations with its principal axis 




gx gy gz A∥ (G) A⊥ (G) R (ns) C20 (kT) S D ( ) D ( )
Vesicle 200 2.00866 2.00641 2.00228 33.89 5.92 - - - - -
Vesicle 298 2.00859 2.00655 2.00225 32.21 5.63 76.2 1.6 0.36 - -
Bicelle
(Global)
298 2.00842 2.00677 2.00242 31.69 5.61 60.5 2.7 0.56 90.0 36.8  
Table 6. Parameters from rigid-limit (200 K) and MOMD (298 K) fits to 32/36-BSL-PLB spectra. 
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not differ significantly from the randomly-oriented vesicle spectrum, as rotational 
diffusion of 32-BSL-PLB in the bicelle further disorders the probe orientation. Therefore, 
32-BSL-PLB demonstrates that monofunctional attachment of BSL does not restrict 
probe dynamics sufficiently to measure orientation with high precision. 
 To extract the helical tilt of PLB’s transmembrane helix from our EPR 
measurements, we modeled BSL onto the high-resolution NMR structure of AFA-PLB 
(PDB 2KB7) [22], using dihedral angles were taken from the crystal structure of BSL-
T4-lysozyme [93]. To confirm the stability of this conformation, we performed a 160 ns 
 
Fig. 49. Molecular dynamics simulation of BSL attached at positions 32 and 36 of the TM helix 
(residues 23-52) of PLB, aligned to PDB 2KB7 structure [207]. 
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molecular dynamics simulation of the 32/36-BSL-PLB transmembrane helix (omitting 
cytoplasmic residues 1-24) in implicit solvent. We found the position and orientation of 
BSL to be largely invariant relative to the helix long axis (h), with our simulation 
reporting an average angle of 67° (FWHM ~ 10°) between h and the nitroxide principal 
axis (zM). This yields a TM helix tilt of 21.4°, in good agreement with the helix tilt of 21° 
determined by NMR [22]. There are likely additional modes of motion besides uniaxial 
diffusion, such as rapid wobble of the helix [208] and dynamics of the spin label relative 
to PLB that may perturb this measurement. When the simulated 32/36-BSL-PLB TM 
helix was aligned to the full 2KB7 structure in lipid bilayer, we measured an average 
angle of 89° (FWHM ~ 5°) between the membrane normal and the nitroxide principal 
axis (zM). This is in excellent agreement with D (90.0°) from our simulated EPR data. 
 
5.5 Conclusions 
 We have shown that a bifunctional methanethiosulfonate spin label (BSL) is 
capable of reporting the structural topology of monomeric PLB reconstituted into 
magnetically-aligned bicelles. Using POPC/DMPC mixed bicelles, we were able to 
prepare oriented samples at physiological temperature (298 K), acquiring spectra from 
both parallel and perpendicular samples. Fitting the randomly oriented samples (vesicles), 
as well as the parallel and perpendicular bicelle spectra simultaneously resulted in 
sufficient fitting convergence. We determined that while both monofunctionally (32-
BSL-PLB) and bifunctionally (32/36-BSL-PLB) attached BSL were immobilized on 
PLB’s TM helix (Fig. 47), bifunctional attachment is necessary for sufficient orientation 
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resolution (Fig. S52). We also determined that at the incorporated position (32,36), BSL 
makes a 90
o
 angle with the membrane normal. This result was well-corroborated with a 
molecular dynamics simulation. 
 In principle, EPR spectroscopy is exquisitely sensitive to the orientation of spin 
labels with respect to the applied magnetic field, although this resolution is usually 
obscured by the rotational mobility of conventional labels. The majority of bicelle EPR 
studies to date have relied on TOAC, which is limited to small proteins. The bifunctional 
spin label used here may be applied to larger proteins, requiring only two cysteine 
mutations on a protein segment with well-ordered secondary structure, such as a helix. 
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Fig. S50. Electrospray ionization (ESI) mass spectrometry of 32/36-BSL-PLB (a) and 32-BSL-
PLB (b). 
























Fig. S51. Conventional EPR spectra of 32/36-BSL-PLB (black) and 32-BSL-PLB (blue) in 
randomly-oriented vesicles at 298 K. 
 



















3300 3320 3340 3360 3380 3400
Magnetic Field (G)
 32-BSL-PLB Vesicle
 32-BSL-PLB + Tm
 32-BSL-PLB + Dy
 
Fig. S52. Conventional EPR spectra of 32-BSL-PLB in randomly oriented vesicles (black), 
parallel oriented bicelles (red), and perpendicular oriented bicelles (blue) at 298 K. 
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Fig. S53. Conventional EPR spectra of 5-DOXYL-stearic acid in randomly oriented vesicles 
(black), parallel oriented bicelles (red), and perpendicular oriented bicelles (blue) at 298 K. 
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Chapter 6: Probing Phospholamban Orientation in the Presence of SERCA 
– Ongoing Research 
 
6.1 Introduction 
 My current research aims to measure PLB orientation within the SERCA-PLB 
complex, to further elucidate the inhibitory and non-inhibitory conformations of PLB. To 
date, no group has performed EPR measurements on large transmembrane protein 
complexes like SERCA-PLB in oriented bicelles. The addition of SERCA to oriented 
bicelle samples requires detergent reconstitution, where detergent is added to 
permeabilize lipid bilayers and facilitate incorporation of large membrane proteins [209]. 
However, there are several challenges to combining detergent reconstitutions with 
bicelles. 
 The short-chain lipid used to prepare bicelles, DHexPC, is quite similar to the 
detergents -octyl glucoside (-OG) and octaethylene glycol monododecyl ether (C12E8), 
meaning that any residual detergent will change the bicelle q. This necessitates adding 
DHexPC after reconstitution and detergent removal, since it would also be removed 
along with the detergent. Also, the cross-sectional area of SERCA is about 16 times 
larger than that of PLB or a typical lipid (~13 nm
2
 vs ~0.8 nm
2
), so these large membrane 
proteins further perturb the effective bicelle q. 
 Prior to studies on PLB orientation in bicelles containing SERCA, we spent a 
considerable amount of time performing control experiments with the 5-DOXYL-stearic 
acid spin label, attempting to characterize the critical aspects of forming and aligning 
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bicelles, with emphasis on the detergent reconstitution needed to prepare SERCA 
bicelles. Chapter 5 highlights optimization of temperature and POPC:DMPC molar ratio 
in bicelles, but several other characteristics were explored. The total concentration of 
lipid with respect to buffer volume is essential for bicelle alignment. Bicelle samples 
where the total lipid concentration is <25% w/v (weight lipid per volume solution) do not 
align well, likely because diluting the bicelles prevents them from forming large lamellar 
sheets at elevated temperature. Exceeding this lipid concentration leads to viscous 
samples that are difficult to pipette and contain lipid aggregation. These observations are 
corroborated by previous NMR studies [210]. Bicelle q is also an important parameter for 
successful alignment. In bicelle samples containing either 5-DOXYL-stearic acid or 
TOAC-AFA, 3 < q < 6 produces sufficient alignment homogeneity, with q ~ 4 being 
optimal. Bicelles with q < 3 become isotropic and will not align, while bicelles with q > 6 
produce a very viscous solution and align poorly. This is approximately the range used in 
NMR experiments [172]. Interestingly, bicelles prepared by the reconstitution method 
(see Section 6.2) show improved alignment at lower q, requiring q ~ 3 even for modest 
alignment. Presumably, residual detergent and/or the effect of SERCA on the flat bilayer 
area necessitate a different bicelle q. Cholesterol is also essential for bicelle alignment. 
The 13% (mol cholesterol / mol LC lipid) used by the Lorigan lab works well [178], with 
less or more cholesterol degrading alignment homogeneity. Finally, the decrease in 
magnetic field strength after bicelle alignment for spectrum acquisition does not seem to 
affect bicelle alignment for well-ordered samples. In one experiment, the magnetic field 
was turned completely off for 30 minutes before acquisition, and demonstrated similar 
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lineshape to those that were acquired immediately after alignment. Temperature is the 
critical parameter for maintaining bicelle alignment, as observed previously [211]. 
 Another technique that has aided experiments is the use of Q-band EPR 
spectroscopy. Fitting the preliminary X-band data proved largely unsuccessful, so we 
sought to constrain the fitting routine further with additional data acquired at Q-band. 
Global fitting of the X-band and Q-band data has improved fit convergence, producing 




 36-TOAC-AFA-PLB (36-TOAC-PLB), phosphorylated 36-TOAC-AFA-PLB 
(36-TOAC-pPLB) and reactive red SERCA were prepared and purified as described 
previously [61]. PLB was combined with lipids (equimolar DMPC and POPC), and 
cholesterol, all dissolved in chloroform. This produced vesicles with 1400 lipids per PLB, 
13% cholesterol (mol cholesterol / mol long-chain lipid). Organic solvent was evaporated 
under N2 gas and then completely removed by storage in a vacuum desiccator overnight. 
Samples were then brought up to 3 mL total volume, 10 mM lipid, 55 mM -OG, and 
100 mM HEPES (pH 7.0) using appropriate stocks. Purified SERCA was added at a 2:1 
molar ratio with PLB, then stirred for five minutes. -OG was adsorbed using Bio-Beads 
SM2 (30 mg Bio-Beads per mg -OG), added in three equal batches over three hours, 
and stirred on an inverter. Samples were then diluted up to 75 mL (to reduce the effect of 
any residual detergent), and centrifuged at 100,000 relative centrifugal force (RCF, or 
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times gravity) at 4 °C for one hour. After removal of supernatant, DHexPC in 100 mM 
HEPES (pH 7.0) was added to the protein/lipid pellet to produce a q ratio of 3, and 
lanthanide stock (TmCl3*6H2O in 100 mM HEPES) was added to the sample up to 20% 
(mol lanthanide / mol long-chain lipid). The sample was vortexed for 2 min and placed 
on ice for 5 min a total of three times, then briefly sonicated. 16 L of the sample was 
pipetted into a 0.6/0.84 mm ID/OD glass capillary, then plugged with Critoseal. 
 X-band / Q-band EPR experiments were performed on a Bruker EleXsys E500 / 
E580 spectrometer equipped with an ER 4122 SHQ / ER 5106 QT resonator. Samples 
were first placed in the resonator and equilibrated at 273 K for 5 min. To align bicelles, 
the field strength was raised to 1.1 T / 1.2 T, then the temperature was raised 2 K per 
minute up to 298 K, at which point the sample was incubated for 20 min at 1.1 T / 1.2 T 
field strength. The EPR spectrum was then acquired at X-band / Q-band field strength 
(~3400 G / ~12000 G) at 298 K. For randomly oriented vesicle samples, spectra were 
acquired immediately after the initial 5 minute equilibration at 298 K. EPR spectra were 
acquired with the parameters specified in Table 7: 
 
6.3 Results 
 Initial experiments with 36-TOAC-AFA began at X-band in the absence of 


















298 3356 120 1 2 20.48 20.48
Q
(35 GHz)
298 12130 200 1 1 20.48 20.48
 
Table 7. EPR acquisition parameters for X-band and Q-band bicelle samples. 
 
  116 
randomly oriented vesicles and bicelles. The substantial change in lineshape between the 
vesicle (black) and bicelle (red) spectra for samples without SERCA (left) is indicative of 
homogeneous alignment, which was also evident in spectral fitting. Phosphorylation had 
little effect on both these vesicle and bicelle sample spectra, indicating that the TM helix 
of PLB is relatively unaffected by phosphorylation in the absence of SERCA. 
 Fig. 54 (right) shows the EPR spectra of 36-TOAC-PLB and 36-TOAC-pPLB 
samples in the presence of 2:1 SERCA:PLB. Comparing the spectra for vesicle and 
bicelle samples containing SERCA, the difference in lineshape is less than that observed 
for the PLB-only samples, suggesting lower alignment homogeneity. Indeed, the spectra 
do not fit well to a single oriented component or to a two-component model containing 









































Fig. 54. X-band EPR spectra of 36-TOAC-PLB (top) and 36-TOAC-pPLB (bottom) in randomly 
oriented vesicles (black) and bicelles aligned parallel with respect to the instrument magnetic field 
(red), in the absence (left) and presence (right) of 2:1 SERCA:PLB. 
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helix adopts several conformations in the presence of SERCA, or the EPR spectra are not 
sufficiently resolved to converge the fitting routine. 
 This result prompted the use of Q-band EPR spectroscopy on 36-TOAC-PLB 
samples, as the potential increased sensitivity to orientation and opportunity for global 
analysis with previous X-band data could resolve the ambiguity observed in the SERCA-
containing samples at X-band. Fig. 55 (left) shows the Q-band EPR spectra of 36-TOAC-
PLB and 36-TOAC-pPLB in randomly oriented vesicles and bicelles, corresponding to 
the X-band EPR spectra shown in Fig. 54. Similar to Fig. 54, the Q-band EPR spectra in 
Fig. 55 demonstrate substantial alignment in bicelle samples, with PLB phosphorylation 
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Fig. 55. Q-band EPR spectra of 36-TOAC-PLB and 36-TOAC-pPLB with and without 2:1 
SERCA:PLB in randomly oriented vesicles and bicelles aligned parallel with respect to the 
instrument magnetic field. 
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SERCA (Fig. 55, right), there are subtle changes in the spectral lineshape upfield of the 
central resonance upon phosphorylation that were not observed in the X-band data.  
 Global fitting of the X-band and Q-band data determined a PLB TM helix tilt 
angle of 35.6° (Fig. 56). This angle differs from the angle determined by NMR (21°) 
































Fig. 56. Diffusion tilt angles for PLB TM helix determined by preliminary fitting of oriented bicelle 
EPR on 36-TOAC-PLB. The diffusion tilt angle () is defined as the angle between the membrane 
normal (A) and the PLB TM helix axis (M) (see center inset). PLB phosphorylation in the absence 
of SERCA (left) causes little change in . SERCA binding causes a significant decrease in , 
while phosphorylation of SERCA-bound PLB partially reverses this decrease in .
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conformation of TOAC upon PLB. Phosphorylation yields D = 35.8°, suggesting no 
significant change in PLB TM helix tilt due to phosphorylation In contrast, SERCA 
binding significantly decreases the PLB TM helix tilt angle to 20.6°, while 




 While still in progress, this research has produced several valuable conclusions 
regarding SERCA bicelle methodology and PLB orientation in the presence of SERCA. 
Well-orienting bicelles possess a high lipid to solvent ratio, a q that has been optimized 
for the system under study, and a modest amount of cholesterol. Additionally, the use of 
multifrequency EPR improves fit convergence significantly over both X-band and Q-
band EPR individually. Using the 36-TOAC-PLB construct, no significant change in TM 
helix tilt is observed for PLB alone after phosphorylation. Binding to SERCA decreases 
the tilt angle, causing the TM helix to be more parallel with the membrane normal. 
Phosphorylation of SERCA-bound PLB partially reverses this tilt change. 
 Several additional experiments need to be conducted for this project before a full 
analysis can be completed. The activity of SERCA, including inhibition by PLB and 
phosphorylation-induced reversal of PLB inhibition, should be verified with calcium-
dependent ATPase functional assays. Calcium should also be regulated in future samples 
with ethylene glycol tetraacetic acid (EGTA), a calcium chelating molecule. Additional 
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trials should be conducted, including with the 32/36-BSL-PLB mutant introduced in 
Chapter 5, since it demonstrated a well-defined orientation distribution. 
 The increase in PLB TM helix tilt upon phosphorylation in the presence of 
SERCA could correspond to a fraction of PLB that has dissociated from SERCA, as 
previous studies have detected decreased binding affinity upon phosphorylation [57, 
212]. This could be evaluated by performing saturation transfer EPR on identical bicelle 
samples, and verify previous results supporting the subunit model still hold in the current 
bicelle system [61]. 
 A limitation to the orientation data obtained in the presence of SERCA is that it 
cannot resolve the direction of PLB’s helical tilt relative to SERCA. This tilt may face 
towards, away, or along the binding interface of SERCA. Cross-linking studies have 
found several residues at the beginning and ends of PLB domain II that are important for 
SERCA binding, suggesting that the tilt may occur along the binding interface [52, 53]. 
Accessibility EPR studies in progress in our laboratory may be able to resolve this by 
detecting changes in PLB residue accessibility upon phosphorylation. 
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Chapter 7: Final Conclusions and Future Directions 
 
 My thesis work has advanced both knowledge of the SERCA-PLB structure-
function relationship, and spectroscopic methods to continue these studies in greater 
detail. Below, I outline the primary methods and results from each chapter, and follow 
with motivation and outline for future experiments. 
 In Chapter 3, I measured the rotational dynamics of PLB as affected by 
phosphorylation and binding to SERCA. By incorporating spin labels into PLB and 
SERCA and reconstituting these proteins into lipid vesicles, I measured their rotational 
mobility by conventional and saturation transfer EPR. I determined that phosphorylation 
of SERCA-bound PLB does not dissociate the SERCA-PLB complex, supporting the 
subunit model of regulation. I also characterized concentration-dependent protein 
oligomerization, identifying conditions where monomeric PLB, SERCA, and SERCA-
PLB complexes can be studied. 
 In Chapter 4, I optimized lipid bicelle composition, reconstituting the 5-DOXYL-
stearic acid lipid spin label into bicelles with different ratios of DMPC and POPC, and 
aligning these bicelles up to different temperatures. Through these experiments, I 
determined that an equimolar mixture of DMPC and POPC reduced the necessary 
alignment temperature by 20 K, compared to conventional DMPC-only bicelles. This 
makes possible orientation measurements on membrane proteins at physiological 
conditions, which is essential for preserving native structure and dynamics. 
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 In Chapter 5, I utilized the bicelle methodology from Chapter 4 to probe PLB 
orientation in its membrane environment. Through cysteine mutagenesis, I attached a 
bifunctional spin label (BSL) at positions 32 and 36 on PLB’s TM helix, and 
reconstituted it into POPC/DMPC bicelles. Through a combination of oriented bicelle 
EPR and molecular dynamics simulations, I found that the principal axis of BSL at 
positions 32/36 on PLB forms a 90° angle with the bilayer normal, and a 76° angle with 
the PLB TM helix axis. From these, I determined a PLB TM helix tilt angle of 21°, 
consistent with previous NMR measurements. I also demonstrated through a single 
cysteine PLB mutant, that monofunctionally attached BSL is not sufficiently restricted 
for orientation measurements. This suggests that singly attached spin labels like MSL and 
MTSL are not suitable for oriented bicelle EPR, and that rigid probes such as TOAC and 
BSL are required. 
 In Chapter 6, I reconstituted 36-TOAC-PLB and SERCA into bicelles to 
determine changes in PLB TM helix tilt angle due to phosphorylation and SERCA 
binding. Control experiments motivated several modifications to the bicelle protocol 
developed in Chapter 4, including detergent reconstitution and reduced bicelle q. 
Preliminary results find no significant change in helix tilt angle after phosphorylation for 
PLB alone, with a 15° decrease in helix tilt upon binding to SERCA, and a partial 
reversal of this decrease upon phosphorylation (5.7°). Along with the results from 
Chapter 3, this suggests that relief of SERCA inhibition by PLB phosphorylation occurs 
by subtle structural changes within the SERCA-PLB transmembrane binding region. 
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Additional EPR measurements with TOAC and functional assays should be performed to 
confirm these results. 
 A wide variety of additional experiments remain to expand upon the results 
presented in this thesis work. The SERCA-PLB dynamics measurements performed in 
Chapter 3 were done at low calcium concentration (pCa = 6.5) to maximize PLB 
inhibition. In vivo, calcium concentration can be several hundred times above this [8]. 
Several studies suggest that PLB has decreased binding affinity, or cannot bind at all, to 
SERCA with calcium bound to it [21, 57, 58]. These results could be verified using the 
same combination of conventional and saturation transfer EPR as used in Chapter 3. 
 Additionally, while dilute protein concentrations were used in those experiments 
to ensure monomeric conditions and simplify analysis, the system is much more crowded 
in vivo (<100 lipids per SERCA vs 700 lipids per SERCA) [213]. Protein 
oligomerization is known to play an important role in calcium regulation; this could be 
investigated using saturation transfer EPR. The possible emergence of multiple 
oligomeric states and spin-spin interactions makes this a difficult measurement, so care 
would be needed to gradually introduce higher oligomeric states, starting with dimers. 
 TOAC and BSL are both rigidly coupled spin labels that can be used to study 
protein dynamics and orientation. However, they differ in their conformation on the 
peptide backbone. On the PLB TM helix, TOAC’s principal axis makes a 14° angle with 
the helix axis, while BSL’s principal axis makes a 76° angle with the helix axis. This 
suggests that TOAC and BSL can be used together to improve orientation measurement 
accuracy. Indeed, comparison of oriented bicelle EPR spectra with 36-TOAC-PLB and 
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32/36-BSL-PLB show this complementary property. This relationship could be further 
characterized and put into practice for enhanced measurements. 
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